HCA Healthcare (HCA) 10-Q 5 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Jul. 31, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'HCA HOLDINGS, INC.	'
Entity Central Index Key	'0000860730	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	432,385,100

CONDENSED_CONSOLIDATED_INCOME_

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) (USD $)	3 Months Ended				6 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2014	Jun. 30, 2013
Income Statement [Abstract]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	$9,958	$9,473	'	'	$19,641	$18,667
Provision for doubtful accounts	728	1,023	'	'	1,579	1,777
Revenues	9,230	8,450	'	'	18,062	16,890
Salaries and benefits	4,098	3,848	'	'	8,148	7,765
Supplies	1,532	1,470	'	'	3,064	2,949
Other operating expenses	1,644	1,507	'	'	3,289	3,030
Electronic health record incentive income	-35	-52	'	'	-65	-91
Equity in earnings of affiliates	-9	-12	'	'	-18	-20
Depreciation and amortization	454	425	'	'	901	849
Interest expense	427	462	'	'	887	934
Losses (gains) on sales of facilities	-11	-4	'	'	-32	12
Losses on retirement of debt	226	'	17	'	226	17
Legal claim costs	'	'	'	175	78	'
Total expenses including equity in earnings of affiliates	8,326	7,644	'	'	16,478	15,445
Income before income taxes	904	806	'	'	1,584	1,445
Provision for income taxes	272	269	'	'	498	470
Net income	632	537	'	'	1,086	975
Net income attributable to noncontrolling interests	149	114	'	'	256	208
Net income attributable to HCA Holdings, Inc.	$483	$423	'	'	$830	$767
Per share data:	'	'	'	'	'	'
Basic earnings per share	$1.10	$0.95	'	'	$1.88	$1.72
Diluted earnings per share	$1.07	$0.91	'	'	$1.82	$1.66
Shares used in earnings per share calculations (in thousands):	'	'	'	'	'	'
Basic	438,833	446,612	'	'	440,482	445,513
Diluted	453,009	463,184	'	'	455,220	462,782

CONDENSED_CONSOLIDATED_COMPREH

CONDENSED CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Statement Of Income And Comprehensive Income [Abstract]	'	'	'	'
Net income	$632	$537	$1,086	$975
Other comprehensive income before taxes:	'	'	'	'
Foreign currency translation	30	'	40	-60
Unrealized gains (losses) on available-for-sale securities	4	-9	8	-8
Defined benefit plans	'	'	'	'
Pension costs included in salaries and benefits	4	8	8	15
Total defined benefit plans	4	8	8	15
Change in fair value of derivative financial instruments	-19	47	-29	40
Interest costs included in interest expense	32	32	65	64
Total change in fair value of derivative financial instruments	13	79	36	104
Other comprehensive income before taxes	51	78	92	51
Income taxes related to other comprehensive income items	18	29	34	20
Other comprehensive income	33	49	58	31
Comprehensive income	665	586	1,144	1,006
Comprehensive income attributable to noncontrolling interests	149	114	256	208
Comprehensive income attributable to HCA Holdings, Inc.	$516	$472	$888	$798

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$658	$414
Accounts receivable, less allowance for doubtful accounts of $5,267 and $5,488	5,472	5,208
Inventories	1,211	1,179
Deferred income taxes	500	489
Other	931	747
Total current assets	8,772	8,037
Property and equipment, at cost	31,841	31,073
Accumulated depreciation	-18,120	-17,454
Property and equipment, net	13,721	13,619
Investments of insurance subsidiaries	426	448
Investments in and advances to affiliates	150	121
Goodwill and other intangible assets	5,909	5,903
Deferred loan costs	230	237
Other	614	466
Total assets	29,822	28,831
Current liabilities:	'	'
Accounts payable	1,717	1,803
Accrued salaries	1,140	1,193
Other accrued expenses	1,992	1,913
Long-term debt due within one year	1,046	786
Total current liabilities	5,895	5,695
Long-term debt	27,942	27,590
Professional liability risks	1,019	949
Income taxes and other liabilities	1,554	1,525
Stockholders' deficit:	'	'
Common stock $0.01 par; authorized 1,800,000,000 shares; outstanding 431,372,800 shares in 2014 and 439,604,000 shares in 2013	4	4
Capital in excess of par value	777	1,386
Accumulated other comprehensive loss	-199	-257
Retained deficit	-8,572	-9,403
Stockholders' deficit attributable to HCA Holdings, Inc.	-7,990	-8,270
Noncontrolling interests	1,402	1,342
Total stockholders' deficit	-6,588	-6,928
Total liabilities and stockholders' deficit	$29,822	$28,831

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, except Share data, unless otherwise specified
Statement Of Financial Position [Abstract]	'	'
Allowance for Accounts receivable	$5,267	$5,488
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, shares outstanding	431,372,800	439,604,000

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net income	$1,086	$975
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Changes in operating assets and liabilities	-2,151	-2,335
Provision for doubtful accounts	1,579	1,777
Depreciation and amortization	901	849
Income taxes	-94	183
Losses (gains) on sales of facilities	-32	12
Losses on retirement of debt	226	17
Legal claim costs	78	'
Amortization of deferred loan costs	23	28
Share-based compensation	77	51
Other	'	-3
Net cash provided by operating activities	1,693	1,554
Cash flows from investing activities:	'	'
Purchase of property and equipment	-913	-896
Acquisition of hospitals and health care entities	-27	-23
Disposition of hospitals and health care entities	32	31
Change in investments	43	102
Other	1	-4
Net cash used in investing activities	-864	-790
Cash flows from financing activities:	'	'
Issuance of long-term debt	3,502	'
Net change in revolving credit facilities	340	-20
Repayment of long-term debt	-3,482	-768
Distributions to noncontrolling interests	-197	-196
Payment of debt issuance costs	-49	-5
Repurchase of common stock	-750	'
Distributions to stockholders	-7	-10
Income tax benefits	75	61
Other	-17	-69
Net cash used in financing activities	-585	-1,007
Change in cash and cash equivalents	244	-243
Cash and cash equivalents at beginning of period	414	705
Cash and cash equivalents at end of period	658	462
Interest payments	899	909
Income tax payments, net	$517	$226

BASIS_OF_PRESENTATION_AND_SIGN

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES	'
	NOTE 1 — BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
	Reporting Entity
	HCA Holdings, Inc. is a holding company whose affiliates own and operate hospitals and related health care entities. The term “affiliates” includes direct and indirect subsidiaries of HCA Holdings, Inc. and partnerships and joint ventures in which such subsidiaries are partners. At June 30, 2014, these affiliates owned and operated 165 hospitals, 115 freestanding surgery centers and provided extensive outpatient and ancillary services. HCA Holdings, Inc.’s facilities are located in 20 states and England. The terms “Company,” “HCA,” “we,” “our” or “us,” as used herein and unless otherwise stated or indicated by context, refer to HCA Holdings, Inc. and its affiliates. The terms “facilities” or “hospitals” refer to entities owned and operated by affiliates of HCA and the term “employees” refers to employees of affiliates of HCA.
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.
	The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $67 million and $65 million for the quarters ended June 30, 2014 and 2013, respectively, and $135 million and $131 million for the six months ended June 30, 2014 and 2013, respectively. Operating results for the quarter and the six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2013.
	Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans (includes the health insurance exchanges, beginning with the first quarter of 2014), commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2014 and 2013 are summarized in the following table (dollars in millions):
		Quarter
		2014			Ratio			2013			Ratio
	Medicare	$	2,040			22.1	%	$	1,976			23.4	%
	Managed Medicare		906			9.8			804			9.5
	Medicaid		588			6.4			365			4.3
	Managed Medicaid		452			4.9			378			4.5
	Managed care and other insurers		4,959			53.8			4,655			55.1
	International (managed care and other insurers)		334			3.6			291			3.4
			9,279			100.6			8,469			100.2
	Uninsured		318			3.4			693			8.2
	Other		361			3.9			311			3.7
	Revenues before provision for doubtful accounts		9,958			107.9			9,473			112.1
	Provision for doubtful accounts		(728	)		(7.9	)		(1,023	)		(12.1	)
	Revenues	$	9,230			100	%	$	8,450			100	%
		Six Months
		2014			Ratio			2013			Ratio
	Medicare	$	4,165			23.1	%	$	4,114			24.4	%
	Managed Medicare		1,805			10			1,647			9.8
	Medicaid		1,032			5.7			697			4.1
	Managed Medicaid		873			4.8			779			4.6
	Managed care and other insurers		9,669			53.5			9,141			54.1
	International (managed care and other insurers)		660			3.7			581			3.4
			18,204			100.8			16,959			100.4
	Uninsured		706			3.9			1,092			6.5
	Other		731			4			616			3.6
	Revenues before provision for doubtful accounts		19,641			108.7			18,667			110.5
	Provision for doubtful accounts		(1,579	)		(8.7	)		(1,777	)		(10.5	)
	Revenues	$	18,062			100	%	$	16,890			100	%
	The increase in Medicaid revenues for the quarter and the six months ended June 30, 2014 compared to the quarter and six months ended June 30, 2013 was primarily due to our recording of $142 million, or $0.20 per diluted share, of Medicaid revenues related to the receipt of reimbursements in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013.
	Certain prior year amounts have been reclassified to conform to the current year presentation.
	Recent Pronouncements
	In May 2014, the Financial Accounting Standards Board and the International Accounting Standards Board issued a final, converged, principles-based standard on revenue recognition. Companies across all industries will use a new five-step model to recognize revenue from customer contracts. The new standard, which replaces nearly all existing United States Generally Accepted Accounting Principles (“US GAAP”) and International Financial Reporting Standards revenue recognition guidance, will require significant management judgment in addition to changing the way many companies recognize revenue in their financial statements. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted under US GAAP. We are evaluating the effects the adoption of this standard will have on our financial statements and financial disclosures.

ACQUISITIONS_AND_DISPOSITIONS

ACQUISITIONS AND DISPOSITIONS	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
ACQUISITIONS AND DISPOSITIONS	'
	NOTE 2 — ACQUISITIONS AND DISPOSITIONS
	During the six months ended June 30, 2014, we paid $14 million to acquire a hospital and $13 million to acquire other nonhospital health care entities. During the six months ended June 30, 2013, we paid $23 million to acquire nonhospital health care entities.
	During the six months ended June 30, 2014, we received proceeds of $32 million and recognized net pretax gains of $32 million related to sales of real estate and other investments. During the six months ended June 30, 2013, we received proceeds of $31 million and recognized net pretax losses of $12 million related to sales of a hospital facility and real estate and other investments.

INCOME_TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	NOTE 3 — INCOME TAXES
	The IRS Examination Division began an audit of HCA Holdings, Inc.’s 2011 and 2012 federal income tax returns during 2014. We are also subject to examination by state and foreign taxing authorities.
	Our liability for unrecognized tax benefits was $507 million, including accrued interest of $40 million, as of June 30, 2014 ($462 million and $30 million, respectively, as of December 31, 2013). Unrecognized tax benefits of $176 million ($160 million as of December 31, 2013) would affect the effective rate, if recognized. The provision for income taxes reflects $4 million and $3 million (each $2 million, net of tax) of interest expense related to taxing authority examinations for the quarters ended June 30, 2014 and 2013, respectively. The provision for income taxes reflects $8 million ($5 million, net of tax) of interest expense related to taxing authority examinations and $15 million ($9 million, net of tax) of reductions in interest expense related to taxing authority examinations for the six months ended June 30, 2014 and 2013, respectively. The provision for income taxes for the quarter and six months ended June 30, 2014 also reflects a reduction of $22 million related primarily to resolutions of prior year examinations.
	Depending on the completion of examinations by federal, state or foreign taxing authorities, the resolution of any tax disputes, or the expiration of statutes of limitation for specific taxing jurisdictions, we believe it is reasonably possible our liability for unrecognized tax benefits may significantly increase or decline within the next 12 months. However, we are currently unable to estimate the range of any possible change.

EARNINGS_PER_SHARE

EARNINGS PER SHARE	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
EARNINGS PER SHARE	'
	NOTE 4 — EARNINGS PER SHARE
	We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.
	The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended June 30, 2014 and 2013 (dollars in millions, except per share amounts, and shares in thousands):
		Quarter				Six Months
		2014		2013		2014		2013
	Net income attributable to HCA Holdings, Inc.	$	483	$	423	$	830	$	767
	Weighted average common shares outstanding		438,833		446,612		440,482		445,513
	Effect of dilutive incremental shares		14,176		16,572		14,738		17,269
	Shares used for diluted earnings per share		453,009		463,184		455,220		462,782
	Earnings per share:
	Basic earnings per share	$	1.1	$	0.95	$	1.88	$	1.72
	Diluted earnings per share	$	1.07	$	0.91	$	1.82	$	1.66

INVESTMENTS_OF_INSURANCE_SUBSI

INVESTMENTS OF INSURANCE SUBSIDIARIES	6 Months Ended
	Jun. 30, 2014
Investments Debt And Equity Securities [Abstract]	'
INVESTMENTS OF INSURANCE SUBSIDIARIES	'
	NOTE 5 — INVESTMENTS OF INSURANCE SUBSIDIARIES
	A summary of our insurance subsidiaries’ investments at June 30, 2014 and December 31, 2013 follows (dollars in millions):
		June 30, 2014
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	447	$	17	$	(1	)	$	463
	Money market funds		29		—		—			29
			476		17		(1	)		492
	Equity securities		1		2		—			3
		$	477	$	19	$	(1	)		495
	Amounts classified as current assets									(69	)
	Investment carrying value								$	426
		December 31, 2013
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	404	$	11	$	(3	)	$	412
	Money market funds		94		—		—			94
			498		11		(3	)		506
	Equity securities		2		2		—			4
		$	500	$	13	$	(3	)		510
	Amounts classified as current assets									(62	)
	Investment carrying value								$	448
	At June 30, 2014 and December 31, 2013, the investments of our insurance subsidiaries were classified as “available-for-sale.” Changes in temporary unrealized gains and losses are recorded as adjustments to other comprehensive income (loss).
	Scheduled maturities of investments in debt securities at June 30, 2014 were as follows (dollars in millions):
		Amortized		Fair
		Cost		Value
	Due in one year or less	$	41	$	41
	Due after one year through five years		232		238
	Due after five years through ten years		90		96
	Due after ten years		113		117
		$	476	$	492
	The average expected maturity of the investments in debt securities at June 30, 2014 was 4.1 years, compared to the average scheduled maturity of 5.7 years. Expected and scheduled maturities may differ because the issuers of certain securities have the right to call, prepay or otherwise redeem such obligations prior to their scheduled maturity date.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	6 Months Ended
	Jun. 30, 2014
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
FINANCIAL INSTRUMENTS	'
	NOTE 6 — FINANCIAL INSTRUMENTS
	Interest Rate Swap Agreements
	We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities for the interest rate swap agreements which have been designated as cash flow hedges. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.
	The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at June 30, 2014 (dollars in millions):
		Notional		Maturity Date		Fair
		Amount				Value
	Pay-fixed interest rate swaps	$	500		December 2014	$	(3	)
	Pay-fixed interest rate swaps		3,000		December 2016		(214	)
	Pay-fixed interest rate swaps		1,000		December 2017		(42	)
	During the next 12 months, we estimate $126 million will be reclassified from other comprehensive income (“OCI”) to interest expense.
	Derivatives — Results of Operations
	The following table presents the effect of our interest rate swaps on our results of operations for the six months ended June 30, 2014 (dollars in millions):
	Derivatives in Cash Flow Hedging Relationships	Amount of Loss		Location of Loss		Amount of Loss
		Recognized in OCI on		Reclassified from		Reclassified from
		Derivatives, Net of  Tax		Accumulated OCI		Accumulated OCI
				into Operations		into Operations
	Interest rate swaps	$	19		Interest expense	$	65
	Credit-risk-related Contingent Features
	We have agreements with each of our derivative counterparties that contain a provision where we could be declared in default on our derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to our default on the indebtedness. As of June 30, 2014, we have not been required to post any collateral related to these agreements. If we had breached these provisions at June 30, 2014, we would have been required to settle our obligations under the agreements at their aggregate, estimated termination value of $269 million.

ASSETS_AND_LIABILITIES_MEASURE

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
ASSETS AND LIABILITIES MEASURED AT FAIR VALUE	'
	NOTE 7 — ASSETS AND LIABILITIES MEASURED AT FAIR VALUE
	Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.
	Cash Traded Investments
	Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.
	Derivative Financial Instruments
	We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.
	Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at June 30, 2014 and December 31, 2013, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.
	The following tables summarize our assets and liabilities measured at fair value on a recurring basis as of June 30, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):
		June 30, 2014
		Fair Value			Fair Value Measurements Using
					Quoted Prices in			Significant Other			Significant
					Active Markets for			Observable Inputs			Unobservable Inputs
					Identical Assets			(Level 2)			(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	463		$	—		$	456		$	7
	Money market funds		29			29			—			—
			492			29			456			7
	Equity securities		3			2			—			1
	Investments of insurance subsidiaries		495			31			456			8
	Less amounts classified as current assets		(69	)		(29	)		(40	)		—
		$	426		$	2		$	416		$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	259		$	—		$	259		$	—
		December 31, 2013
					Fair Value Measurements Using
		Fair Value			Quoted Prices in			Significant Other			Significant
					Active Markets for			Observable Inputs			Unobservable Inputs
					Identical Assets			(Level 2)			(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	412		$	—		$	405		$	7
	Money market funds		94			94			—			—
			506			94			405			7
	Equity securities		4			3			—			1
	Investments of insurance subsidiaries		510			97			405			8
	Less amounts classified as current assets		(62	)		(62	)		—			—
		$	448		$	35		$	405		$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	295		$	—		$	295		$	—
	The estimated fair value of our long-term debt was $30.449 billion and $29.603 billion at June 30, 2014 and December 31, 2013, respectively, compared to carrying amounts aggregating $28.988 billion and $28.376 billion, respectively. The estimates of fair value are generally based upon the quoted market prices or quoted market prices for similar issues of long-term debt with the same maturities.

LONGTERM_DEBT

LONG-TERM DEBT	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
LONG-TERM DEBT	'
	NOTE 8 — LONG-TERM DEBT
	A summary of long-term debt at June 30, 2014 and December 31, 2013, including related interest rates at June 30, 2014, follows (dollars in millions):
		June 30,		December 31,
		2014		2013
	Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,500	$	2,440
	Senior secured revolving credit facility (effective interest rate of 1.7%)		280		—
	Senior secured term loan facilities (effective interest rate of 5.3%)		5,558		5,598
	Senior secured first lien notes (effective interest rate of 5.8%)		10,491		9,695
	Other senior secured debt (effective interest rate of 6.7%)		464		448
	First lien debt		19,293		18,181
	Senior unsecured notes (effective interest rate of 7.2%)		9,695		10,195
	Total debt (average life of 6.4 years, rates averaging 5.8%)		28,988		28,376
	Less amounts due within one year		1,046		786
		$	27,942	$	27,590
	2014 Activity
	During March 2014, we issued $3.500 billion aggregate principal amount of notes, comprised of $1.500 billion aggregate principal amount of 3.75% senior secured notes due 2019 and $2.000 billion aggregate principal amount of 5.00% senior secured notes due 2024, and repaid at maturity all $500 million aggregate principal amount of our outstanding 5.75% senior unsecured notes. During April 2014, we used proceeds from the March 2014 debt issuance to redeem all $1.500 billion aggregate principal amount of our outstanding 8 1/2% senior secured notes due 2019 and all $1.250 billion aggregate principal amount of our outstanding 7 7/8% senior secured notes due 2020. The pretax loss on retirement of debt related to these redemptions was $226 million.
	2013 Activity
	During March 2013, we redeemed all $201 million aggregate principal amount of our 9 7/8% senior secured second lien notes due 2017. The pretax loss on retirement of debt related to this redemption was $17 million.

CONTINGENCIES_AND_LEGAL_CLAIM_

CONTINGENCIES AND LEGAL CLAIM COSTS	6 Months Ended
	Jun. 30, 2014
Commitments And Contingencies Disclosure [Abstract]	'
CONTINGENCIES AND LEGAL CLAIM COSTS	'
	NOTE 9 — CONTINGENCIES AND LEGAL CLAIM COSTS
	We operate in a highly regulated and litigious industry. As a result, various lawsuits, claims and legal and regulatory proceedings have been and can be expected to be instituted or asserted against us. We are also subject to claims and suits arising in the ordinary course of business, including claims for personal injuries or wrongful restriction of, or interference with, physicians’ staff privileges. In certain of these actions the claimants may seek punitive damages against us which may not be covered by insurance. The resolution of any such lawsuits, claims or legal and regulatory proceedings could have a material, adverse effect on our results of operations or financial position.
	Government Investigations, Claims and Litigation
	Health care companies are subject to numerous investigations by various governmental agencies. Further, under the federal False Claims Act (“FCA”), private parties have the right to bring qui tam, or “whistleblower,” suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Certain of our individual facilities have received, and from time to time, other facilities may receive, government inquiries from, and may be subject to investigation by, federal and state agencies. Depending on whether the underlying conduct in these or future inquiries or investigations could be considered systemic, their resolution could have a material, adverse effect on our financial position, results of operations and liquidity.
	As initially disclosed in 2010, the Civil Division of the Department of Justice (“DOJ”) has contacted the Company in connection with its nationwide review of whether, in certain cases, hospital charges to the federal government relating to implantable cardio-defibrillators (“ICDs”) met the CMS criteria. In connection with this nationwide review, the DOJ has indicated that it will be reviewing certain ICD billing and medical records at 95 HCA hospitals; the review covers the period from October 2003 to the present. In August 2012, HCA, along with non-HCA hospitals across the country subject to the DOJ’s review, received from the DOJ a proposed framework for resolving the DOJ’s review of ICDs. The Company is cooperating in the review. The review could potentially give rise to claims against the Company under the federal FCA or other statutes, regulations or laws. At this time, we cannot predict what effect, if any, this review or any resulting claims could have on the Company.
	In July 2012, the Civil Division of the U.S. Attorney’s Office in Miami requested information on reviews assessing the medical necessity of interventional cardiology services provided at any Company facility (other than peer reviews). The Company is cooperating with the government’s request and has produced medical records associated with particular reviews at eight hospitals, located primarily in Florida. At this time, we cannot predict what effect, if any, the request or any resulting claims, including any potential claims under the federal FCA, other statutes, regulations or laws, could have on the Company.
	On April 2, 2014, the UK Competition and Markets Authority (“Authority”) issued a final report on its investigation of the private health care market in London. It concluded, among other things, that many private hospitals face little competition in central London, and that there are high barriers to entry. As part of its remedies package, the Authority ordered HCA to sell either: (a) its London Bridge and Princess Grace hospitals; or (b) its Wellington Hospital, including the Hospital Platinum Medical Centre. It also imposed other remedial conditions on HCA and other private health care providers, including: regulation of incentives to referring physicians; increased access to information about fees and performance; and restrictions on future arrangements between private providers and National Health Service private patient units. HCA disagrees with the Authority’s assessment of the competitive conditions for hospitals in London, as well as its proposed divestiture remedy, and has appealed the decision to the Competition Appeal Tribunal. The appeal is expected to be decided in 2015.
	Securities Class Action Litigation
	On October 28, 2011, a shareholder action, Schuh v. HCA Holdings, Inc. et al., was filed in the United States District Court for the Middle District of Tennessee seeking monetary relief. The case sought to include as a class all persons who acquired the Company’s stock pursuant or traceable to the Company’s Registration Statement issued in connection with the March 9, 2011 initial public offering. The lawsuit asserted a claim under Section 11 of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserted a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors. The action alleged various deficiencies in the Company’s disclosures in the Registration Statement. Subsequently, two additional class action complaints, Kishtah v. HCA Holdings, Inc. et al. and Daniels v. HCA Holdings, Inc. et al., setting forth substantially similar claims against substantially the same defendants were filed in the same federal court on November 16, 2011 and December 12, 2011, respectively. All three of the cases were consolidated. On May 3, 2012, the court appointed New England Teamsters & Trucking Industry Pension Fund as Lead Plaintiff for the consolidated action. On July 13, 2012, the lead plaintiff filed an amended complaint asserting claims under Sections 11 and 12(a)(2) of the Securities Act of 1933 against the Company, certain members of the board of directors, and certain underwriters in the offering. It further asserts a claim under Section 15 of the Securities Act of 1933 against the same members of the board of directors and Hercules Holdings II, LLC, a majority shareholder of the Company at the time of the initial public offering. The consolidated complaint alleges deficiencies in the Company’s disclosures in the Registration Statement and Prospectus relating to: (1) the accounting for the Company’s 2006 recapitalization and 2010 reorganization; (2) the Company’s failure to maintain effective internal controls relating to its accounting for such transactions; and (3) the Company’s Medicare and Medicaid revenue growth rates. The Company and other defendants moved to dismiss the amended complaint on September 11, 2012. The Court granted the motion in part on May 28, 2013. The action is proceeding to discovery on the remaining claims. Plaintiffs’ motion to certify the class has been briefed and is set for oral argument in August 2014. It is not known when the court will rule on the motion.
	In addition to the above described shareholder class actions, on December 8, 2011, a federal shareholder derivative action, Sutton v. Bracken, et al., putatively initiated in the name of the Company, was filed in the United States District Court for the Middle District of Tennessee against certain officers and present and former directors of the Company seeking monetary relief. The action alleges breaches of fiduciary duties by the named officers and directors in connection with the accounting and earnings claims set forth in the shareholder class actions. Setting forth substantially similar claims against substantially the same defendants, an additional federal derivative action, Schroeder v. Bracken, et al., was filed in the United States District Court for the Middle District of Tennessee on December 16, 2011, and a state derivative action, Bagot v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court on December 20, 2011. The federal derivative actions were consolidated in the Middle District of Tennessee and stayed pending developments in the shareholder class actions. The state derivative action had also been stayed pending developments in the shareholder class actions, but that stay has expired. The plaintiff in the state derivative action subsequently filed an amended complaint on September 9, 2013 that added additional allegations made in the shareholder class actions. On September 24, 2013, an additional state derivative action, Steinberg v. Bracken, et al., was filed in Tennessee state court in the Davidson County Circuit Court. This action against our board of directors has been consolidated with the earlier filed state derivative action. The plaintiffs in the consolidated action filed a consolidated complaint on December 4, 2013. The Company has filed a motion to again stay the state derivative action pending developments in the class action, but the Court has not yet acted on that motion.
	Health Midwest Litigation
	In October 2009, the Health Care Foundation of Greater Kansas City, a nonprofit health foundation, filed suit against HCA Inc. in the Circuit Court of Jackson County, Missouri and alleged that HCA did not fund the level of capital expenditures and uncompensated care agreed to in connection with HCA’s purchase of hospitals from Health Midwest in 2003. The central issue in the case was whether HCA’s construction of new hospitals counted towards its $450 million five-year capital commitments. In addition, the plaintiff alleged that HCA did not make its required capital expenditures in a timely fashion. On January 24, 2013, the Court ruled in favor of the plaintiff and awarded at least $162 million. The Court also ordered a court-supervised accounting of HCA’s capital expenditures, as well as of expenditures on charity and uncompensated care during the ten years following the purchase. The Court also indicated it would award plaintiff attorneys fees, which the parties have stipulated are approximately $12 million for the trial phase. HCA recorded $175 million of legal claim costs in the fourth quarter of 2012 related to this ruling, and consistent with the judge’s order, has been accruing interest on that sum at 9% per annum. On April 25, 2014, the parties stipulated to an additional $78 million shortfall relating to the capital expenditures issue. HCA recorded $78 million of legal claims costs in the first quarter of 2014 as a result of the stipulation, and is accruing interest on that amount at 9% per annum. Pursuant to the terms of the stipulation, the parties have preserved their respective rights to contest the judge’s underlying ruling, whether through motions in the trial court or on appeal. The accounting for charity and other uncompensated care is ongoing, with hearings set to begin in the third quarter of 2014. Final judgment in the case currently is not anticipated before the fourth quarter of 2014. At this time, we cannot predict what effect, if any, the final judgment could have on the Company. HCA plans to appeal the trial court’s ruling on the breach of contract claim and order for the accounting once the trial court rules on the accounting and enters judgment.

CAPITAL_STRUCTURE

CAPITAL STRUCTURE	6 Months Ended
	Jun. 30, 2014
Text Block [Abstract]	'
CAPITAL STRUCTURE	'
	NOTE 10 — CAPITAL STRUCTURE
	The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):
		Equity (Deficit) Attributable to HCA Holdings, Inc.														Equity			Total
																Attributable to
		Common Stock					Capital in			Accumulated			Retained			Noncontrolling
							Excess of			Other			Deficit			Interests
							Par			Comprehensive
		Shares			Par Value		Value			Loss
		0
	Balances at December 31, 2013		439,604		$	4	$	1,386		$	(257	)	$	(9,403	)	$	1,342		$	(6,928	)
	Net income		—			—		—			—			830			256			1,086
	Repurchase of common stock		(14,555	)		—		(750	)		—			—			—			(750	)
	Other comprehensive income		—			—		—			58			—			—			58
	Distributions		—			—		—			—			—			(197	)		(197	)
	Share-based benefit plans		6,324			—		146			—			—			—			146
	Other		—			—		(5	)		—			1			1			(3	)
	Balances at June 30, 2014		431,373		$	4	$	777		$	(199	)	$	(8,572	)	$	1,402		$	(6,588	)
	During May 2014, we repurchased 14,554,628 shares of our common stock at a price of $51.53 per share.
	The components of accumulated other comprehensive loss are as follows (dollars in millions):
		Unrealized			Foreign		Defined			Change			Total
		Gains on			Currency		Benefit			in Fair
		Available-			Translation		Plans			Value of
		for-Sale			Adjustments					Derivative
		Securities								Instruments
	Balances at December 31, 2013	$	7		$	11	$	(88	)	$	(187	)	$	(257	)
	Unrealized gains on available-for-sale securities, net of $3 of income taxes		5			—		—			—			5
	Foreign currency translation adjustments, net of $14 of income taxes		—			26		—			—			26
	Change in fair value of derivative instruments, net of $10 income tax benefit		—			—		—			(19	)		(19	)
	Expense reclassified into operations from other comprehensive income, net of $3 and $24, respectively, income tax benefits		—			—		5			41			46
	Balances at June 30, 2014	$	12		$	37	$	(83	)	$	(165	)	$	(199

SEGMENT_AND_GEOGRAPHIC_INFORMA

SEGMENT AND GEOGRAPHIC INFORMATION	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
SEGMENT AND GEOGRAPHIC INFORMATION	'
	NOTE 11 — SEGMENT AND GEOGRAPHIC INFORMATION
	We operate in one line of business, which is operating hospitals and related health care entities. Effective January 1, 2013, we reorganized our operational groups into two geographically organized groups: the National and American Groups. The National Group includes 82 hospitals located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia, and the American Group includes 77 hospitals located in Colorado, northern Georgia, Kansas, southern Kentucky, Louisiana, Mississippi, Missouri, Oklahoma, Tennessee and Texas. We also operate six hospitals in England, and these facilities are included in the Corporate and other group.
	Adjusted segment EBITDA is defined as income before depreciation and amortization, interest expense, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs, income taxes and net income attributable to noncontrolling interests. We use adjusted segment EBITDA as an analytical indicator for purposes of allocating resources to geographic areas and assessing their performance. Adjusted segment EBITDA is commonly used as an analytical indicator within the health care industry, and also serves as a measure of leverage capacity and debt service ability. Adjusted segment EBITDA should not be considered as a measure of financial performance under generally accepted accounting principles, and the items excluded from adjusted segment EBITDA are significant components in understanding and assessing financial performance. Because adjusted segment EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, adjusted segment EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and six months ended June 30, 2014 and 2013 are summarized in the following table (dollars in millions):
		Quarter						Six Months
		2014			2013			2014			2013
	Revenues:
	National Group	$	4,267		$	3,964		$	8,427		$	7,945
	American Group		4,447			4,065			8,599			8,099
	Corporate and other		516			421			1,036			846
		$	9,230		$	8,450		$	18,062		$	16,890
	Equity in earnings of affiliates:
	National Group	$	(3	)	$	(3	)	$	(6	)	$	(5	)
	American Group		(8	)		(7	)		(15	)		(13	)
	Corporate and other		2			(2	)		3			(2	)
		$	(9	)	$	(12	)	$	(18	)	$	(20	)
	Adjusted segment EBITDA:
	National Group	$	946		$	831		$	1,802		$	1,635
	American Group		1,134			916			1,984			1,744
	Corporate and other		(80	)		(58	)		(142	)		(122	)
		$	2,000		$	1,689		$	3,644		$	3,257
	Depreciation and amortization:
	National Group	$	190		$	177		$	377		$	351
	American Group		211			202			416			404
	Corporate and other		53			46			108			94
		$	454		$	425		$	901		$	849
	Adjusted segment EBITDA	$	2,000		$	1,689		$	3,644		$	3,257
	Depreciation and amortization		454			425			901			849
	Interest expense		427			462			887			934
	Losses (gains) on sales of facilities		(11	)		(4	)		(32	)		12
	Losses on retirement of debt		226			—			226			17
	Legal claim costs		—			—			78			—
	Income before income taxes	$	904		$	806		$	1,584		$	1,445

SUPPLEMENTAL_CONDENSED_CONSOLI

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION	6 Months Ended
	Jun. 30, 2014
Text Block [Abstract]	'
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION	'
	NOTE 12 — SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION
	On November 23, 2010, HCA Holdings, Inc. issued $1.525 billion aggregate principal amount of 7 3/4% senior unsecured notes due 2021. On December 6, 2012, HCA Holdings, Inc. issued $1.000 billion aggregate principal amount of 6.25% senior unsecured notes due 2021. These notes are senior unsecured obligations and are not guaranteed by any of our subsidiaries.
	HCA Inc., a direct wholly-owned subsidiary of HCA Holdings, Inc., is the obligor under a significant portion of our other indebtedness, including our senior secured credit facilities, senior secured notes and senior unsecured notes (other than the senior unsecured notes issued by HCA Holdings, Inc.). The senior secured notes and senior unsecured notes issued by HCA Inc. are fully and unconditionally guaranteed by HCA Holdings, Inc. The senior secured credit facilities and senior secured notes are fully and unconditionally guaranteed by substantially all existing and future, direct and indirect, 100% owned material domestic subsidiaries that are “Unrestricted Subsidiaries” under our Indenture dated December 16, 1993 (except for certain special purpose subsidiaries that only guarantee and pledge their assets under our senior secured asset-based revolving credit facility).
	Our summarized condensed consolidating comprehensive income statements for the quarters and six months ended June 30, 2014 and 2013, condensed consolidating balance sheets at June 30, 2014 and December 31, 2013 and condensed consolidating statements of cash flows for the six months ended June 30, 2014 and 2013, segregating HCA Holdings, Inc. issuer, HCA Inc. issuer, the subsidiary guarantors, the subsidiary non-guarantors and eliminations, follow:
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE QUARTER ENDED JUNE 30, 2014
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Revenues before provision for doubtful accounts	$	—		$	—		$	5,079		$	4,879		$	—		$	9,958
	Provision for doubtful accounts		—			—			394			334			—			728
	Revenues		—			—			4,685			4,545			—			9,230
	Salaries and benefits		—			—			2,118			1,980			—			4,098
	Supplies		—			—			805			727			—			1,532
	Other operating expenses		5			—			789			850			—			1,644
	Electronic health record incentive income		—			—			(24	)		(11	)		—			(35	)
	Equity in earnings of affiliates		(549	)		—			(1	)		(8	)		549			(9	)
	Depreciation and amortization		—			—			224			230			—			454
	Interest expense		46			536			(112	)		(43	)		—			427
	Gains on sales of facilities		—			—			(11	)		—			—			(11	)
	Losses on retirement of debt		—			226			—			—			—			226
	Management fees		—			—			(176	)		176			—			—
			(498	)		762			3,612			3,901			549			8,326
	Income (loss) before income taxes		498			(762	)		1,073			644			(549	)		904
	Provision (benefit) for income taxes		(18	)		(277	)		381			186			—			272
	Net income (loss)		516			(485	)		692			458			(549	)		632
	Net income attributable to noncontrolling interests		—			—			18			131			—			149
	Net income (loss) attributable to HCA Holdings, Inc.	$	516		$	(485	)	$	674		$	327		$	(549	)	$	483
	Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	516		$	(477	)	$	677		$	349		$	(549	)	$	516
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE QUARTER ENDED JUNE 30, 2013
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Revenues before provision for doubtful accounts	$	—		$	—		$	5,012		$	4,461		$	—		$	9,473
	Provision for doubtful accounts		—			—			608			415			—			1,023
	Revenues		—			—			4,404			4,046			—			8,450
	Salaries and benefits		—			—			2,058			1,790			—			3,848
	Supplies		—			—			776			694			—			1,470
	Other operating expenses		1			—			757			749			—			1,507
	Electronic health record incentive income		—			—			(33	)		(19	)		—			(52	)
	Equity in earnings of affiliates		(504	)		—			(1	)		(11	)		504			(12	)
	Depreciation and amortization		—			—			211			214			—			425
	Interest expense		51			544			(109	)		(24	)		—			462
	Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
	Management fees		—			—			(181	)		181			—			—
			(452	)		544			3,481			3,567			504			7,644
	Income (loss) before income taxes		452			(544	)		923			479			(504	)		806
	Provision (benefit) for income taxes		(20	)		(213	)		354			148			—			269
	Net income (loss)		472			(331	)		569			331			(504	)		537
	Net income attributable to noncontrolling interests		—			—			16			98			—			114
	Net income (loss) attributable to HCA Holdings, Inc.	$	472		$	(331	)	$	553		$	233		$	(504	)	$	423
	Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	472		$	(283	)	$	558		$	229		$	(504	)	$	472
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE SIX MONTHS ENDED JUNE 30, 2014
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
Issuer								Guarantors
Revenues before provision for doubtful accounts	$	—		$	—		$	10,109		$	9,532		$	—		$	19,641
Provision for doubtful accounts		—			—			931			648			—			1,579
Revenues		—			—			9,178			8,884			—			18,062
Salaries and benefits		—			—			4,217			3,931			—			8,148
Supplies		—			—			1,619			1,445			—			3,064
Other operating expenses		10			—			1,562			1,717			—			3,289
Electronic health record incentive income		—			—			(46	)		(19	)		—			(65	)
Equity in earnings of affiliates		(952	)		—			(2	)		(16	)		952			(18	)
Depreciation and amortization		—			—			442			459			—			901
Interest expense		92			1,093			(234	)		(64	)		—			887
Gains on sales of facilities		—			—			(32	)		—			—			(32	)
Losses on retirement of debt		—			226			—			—			—			226
Legal claim costs		—			78			—			—			—			78
Management fees		—			—			(350	)		350			—			—
		(850	)		1,397			7,176			7,803			952			16,478
Income (loss) before income taxes		850			(1,397	)		2,002			1,081			(952	)		1,584
Provision (benefit) for income taxes		(38	)		(524	)		733			327			—			498
Net income (loss)		888			(873	)		1,269			754			(952	)		1,086
Net income attributable to noncontrolling interests		—			—			47			209			—			256
Net income (loss) attributable to HCA Holdings, Inc.	$	888		$	(873	)	$	1,222		$	545		$	(952	)	$	830
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	888		$	(851	)	$	1,227		$	576		$	(952	)	$	888
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
FOR THE SIX MONTHS ENDED JUNE 30, 2013
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
Revenues before provision for doubtful accounts	$	—		$	—		$	9,884		$	8,783		$	—		$	18,667
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Revenues		—			—			8,833			8,057			—			16,890
Salaries and benefits		—			—			4,185			3,580			—			7,765
Supplies		—			—			1,567			1,382			—			2,949
Other operating expenses		2			—			1,489			1,539			—			3,030
Electronic health record incentive income		—			—			(62	)		(29	)		—			(91	)
Equity in earnings of affiliates		(860	)		—			(2	)		(18	)		860			(20	)
Depreciation and amortization		—			—			420			429			—			849
Interest expense		97			1,102			(215	)		(50	)		—			934
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(364	)		364			—			—
		(761	)		1,119			7,037			7,190			860			15,445
Income (loss) before income taxes		761			(1,119	)		1,796			867			(860	)		1,445
Provision (benefit) for income taxes		(37	)		(425	)		671			261			—			470
Net income (loss)		798			(694	)		1,125			606			(860	)		975
Net income attributable to noncontrolling interests		—			—			29			179			—			208
Net income (loss) attributable to HCA Holdings, Inc.	$	798		$	(694	)	$	1,096		$	427		$	(860	)	$	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	798		$	(630	)	$	1,105		$	385		$	(860	)	$	798
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
30-Jun-14
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	215		$	443		$	—		$	658
Accounts receivable, net		—			—			2,709			2,763			—			5,472
Inventories		—			—			707			504			—			1,211
Deferred income taxes		500			—			—			—			—			500
Other		—			—			344			587			—			931
		500			—			3,975			4,297			—			8,772
Property and equipment, net		—			—			7,676			6,045			—			13,721
Investments of insurance subsidiaries		—			—			—			426			—			426
Investments in and advances to affiliates		21,308			—			15			135			(21,308	)		150
Goodwill and other intangible assets		—			—			1,694			4,215			—			5,909
Deferred loan costs		27			203			—			—			—			230
Other		406			—			19			189			—			614
	$	22,241		$	203		$	13,379		$	15,307		$	(21,308	)	$	29,822
LIABILITIES AND
STOCKHOLDERS’ (DEFICIT)
EQUITY
Current liabilities:
Accounts payable	$	4		$	—		$	1,081		$	632		$	—		$	1,717
Accrued salaries		—			—			656			484			—			1,140
Other accrued expenses		407			330			433			822			—			1,992
Long-term debt due within one year		—			952			50			44			—			1,046
		411			1,282			2,220			1,982			—			5,895
Long-term debt		2,525			25,047			183			187			—			27,942
Intercompany balances		26,762			(10,203	)		(20,098	)		3,539			—			—
Professional liability risks		—			—			—			1,019			—			1,019
Income taxes and other liabilities		533			260			543			218			—			1,554
		30,231			16,386			(17,152	)		6,945			—			36,410
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(7,990	)		(16,183	)		30,412			7,079			(21,308	)		(7,990	)
Noncontrolling interests		—			—			119			1,283			—			1,402
		(7,990	)		(16,183	)		30,531			8,362			(21,308	)		(6,588	)
	$	22,241		$	203		$	13,379		$	15,307		$	(21,308	)	$	29,822
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING BALANCE SHEET
31-Dec-13
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
ASSETS
Current assets:
Cash and cash equivalents	$	—		$	—		$	112		$	302		$	—		$	414
Accounts receivable, net		—			—			2,565			2,643			—			5,208
Inventories		—			—			692			487			—			1,179
Deferred income taxes		489			—			—			—			—			489
Other		—			—			301			446			—			747
		489			—			3,670			3,878			—			8,037
Property and equipment, net		—			—			7,504			6,115			—			13,619
Investments of insurance subsidiaries		—			—			—			448			—			448
Investments in and advances to affiliates		20,356			—			13			108			(20,356	)		121
Goodwill and other intangible assets		—			—			1,695			4,208			—			5,903
Deferred loan costs		30			207			—			—			—			237
Other		250			—			48			168			—			466
	$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,169		$	633		$	—		$	1,803
Accrued salaries		—			—			694			499			—			1,193
Other accrued expenses		272			353			464			824			—			1,913
Long-term debt due within one year		—			702			45			39			—			786
		273			1,055			2,372			1,995			—			5,695
Long-term debt		2,525			24,701			181			183			—			27,590
Intercompany balances		26,107			(10,513	)		(19,428	)		3,834			—			—
Professional liability risks		—			—			—			949			—			949
Income taxes and other liabilities		490			296			521			218			—			1,525
		29,395			15,539			(16,354	)		7,179			—			35,759
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,270	)		(15,332	)		29,185			6,503			(20,356	)		(8,270	)
Noncontrolling interests		—			—			99			1,243			—			1,342
		(8,270	)		(15,332	)		29,284			7,746			(20,356	)		(6,928	)
	$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2014
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)	$	888		$	(873	)	$	1,269		$	754		$	(952	)	$	1,086
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		13			(32	)		(1,258	)		(874	)		—			(2,151	)
Provision for doubtful accounts		—			—			931			648			—			1,579
Depreciation and amortization		—			—			442			459			—			901
Income taxes		(94	)		—			—			—			—			(94	)
Gains on sales of facilities		—			—			(32	)		—			—			(32	)
Losses on retirement of debt		—			226			—			—			—			226
Legal claim costs		—			78			—			—			—			78
Amortization of deferred loan costs		2			21			—			—			—			23
Share-based compensation		77			—			—			—			—			77
Equity in earnings of affiliates		(952	)		—			—			—			952			—
Other		—			1			—			(1	)		—			—
Net cash (used in) provided by operating activities		(66	)		(579	)		1,352			986			—			1,693
Cash flows from investing activities:
Purchase of property and equipment		—			—			(583	)		(330	)		—			(913	)
Acquisition of hospitals and health care entities		—			—			(2	)		(25	)		—			(27	)
Disposition of hospitals and health care entities		—			—			25			7			—			32
Change in investments		—			—			26			17			—			43
Other		—			—			—			1			—			1
Net cash used in investing activities		—			—			(534	)		(330	)		—			(864	)
Cash flows from financing activities:
Issuance of long-term debt		—			3,502			—			—			—			3,502
Net change in revolving credit facilities		—			340			—			—			—			340
Repayment of long-term debt		—			(3,441	)		(25	)		(16	)		—			(3,482	)
Distributions to noncontrolling interests		—			—			(27	)		(170	)		—			(197	)
Payment of debt issuance costs		—			(49	)		—			—			—			(49	)
Repurchase of common stock		(750	)		—			—			—			—			(750	)
Distributions to stockholders		(7	)		—			—			—			—			(7	)
Changes in intercompany balances with affiliates, net		756			227			(663	)		(320	)		—			—
Income tax benefits		75			—			—			—			—			75
Other		(8	)		—			—			(9	)		—			(17	)
Net cash provided by (used in) financing activities		66			579			(715	)		(515	)		—			(585	)
Change in cash and cash equivalents		—			—			103			141			—			244
Cash and cash equivalents at beginning of period		—			—			112			302			—			414
Cash and cash equivalents at end of period	$	—		$	—		$	215		$	443		$	—		$	658
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2013
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
Cash flows from operating activities:
Net income (loss)	$	798		$	(694	)	$	1,125		$	606		$	(860	)	$	975
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Changes in operating assets and liabilities		41			(18	)		(1,217	)		(1,141	)		—			(2,335	)
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Depreciation and amortization		—			—			420			429			—			849
Income taxes		183			—			—			—			—			183
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Amortization of deferred loan costs		2			26			—			—			—			28
Share-based compensation		51			—			—			—			—			51
Equity in earnings of affiliates		(860	)		—			—			—			860			—
Other		—			4			—			(7	)		—			(3	)
Net cash provided by (used in) operating activities		215			(665	)		1,398			606			—			1,554
Cash flows from investing activities:
Purchase of property and equipment		—			—			(434	)		(462	)		—			(896	)
Acquisition of hospitals and health care entities		—			—			—			(23	)		—			(23	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			5			97			—			102
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(413	)		(377	)		—			(790	)
Cash flows from financing activities:
Net change in revolving credit facilities		—			(20	)		—			—			—			(20	)
Repayment of long-term debt		—			(726	)		(22	)		(20	)		—			(768	)
Distributions to noncontrolling interests		—			—			(29	)		(167	)		—			(196	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(216	)		1,416			(1,165	)		(35	)		—			—
Income tax benefits		61			—			—			—			—			61
Other		(72	)		—			—			3			—			(69	)
Net cash (used in) provided by financing activities		(237	)		665			(1,216	)		(219	)		—			(1,007	)
Change in cash and cash equivalents		(22	)		—			(231	)		10			—			(243	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	152		$	310		$	—		$	462

BASIS_OF_PRESENTATION_AND_SIGN1

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Basis of Presentation	'
	Basis of Presentation
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles for complete consolidated financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal and recurring nature.
	The majority of our expenses are “costs of revenues” items. Costs that could be classified as general and administrative would include our corporate office costs, which were $67 million and $65 million for the quarters ended June 30, 2014 and 2013, respectively, and $135 million and $131 million for the six months ended June 30, 2014 and 2013, respectively. Operating results for the quarter and the six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the consolidated financial statements and footnotes thereto included in our annual report on Form 10-K for the year ended December 31, 2013.
	Revenues are recorded during the period the health care services are provided, based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under Medicare, Medicaid and other programs), managed care health plans (includes the health insurance exchanges, beginning with the first quarter of 2014), commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Revenues related to uninsured patients and copayment and deductible amounts for patients who have health care coverage may have discounts applied (uninsured discounts and contractual discounts). We also record a provision for doubtful accounts related to uninsured accounts to record the net self pay revenues at the estimated amounts we expect to collect. Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2014 and 2013 are summarized in the following table (dollars in millions):
		Quarter
		2014			Ratio			2013			Ratio
	Medicare	$	2,040			22.1	%	$	1,976			23.4	%
	Managed Medicare		906			9.8			804			9.5
	Medicaid		588			6.4			365			4.3
	Managed Medicaid		452			4.9			378			4.5
	Managed care and other insurers		4,959			53.8			4,655			55.1
	International (managed care and other insurers)		334			3.6			291			3.4
			9,279			100.6			8,469			100.2
	Uninsured		318			3.4			693			8.2
	Other		361			3.9			311			3.7
	Revenues before provision for doubtful accounts		9,958			107.9			9,473			112.1
	Provision for doubtful accounts		(728	)		(7.9	)		(1,023	)		(12.1	)
	Revenues	$	9,230			100	%	$	8,450			100	%
		Six Months
		2014			Ratio			2013			Ratio
	Medicare	$	4,165			23.1	%	$	4,114			24.4	%
	Managed Medicare		1,805			10			1,647			9.8
	Medicaid		1,032			5.7			697			4.1
	Managed Medicaid		873			4.8			779			4.6
	Managed care and other insurers		9,669			53.5			9,141			54.1
	International (managed care and other insurers)		660			3.7			581			3.4
			18,204			100.8			16,959			100.4
	Uninsured		706			3.9			1,092			6.5
	Other		731			4			616			3.6
	Revenues before provision for doubtful accounts		19,641			108.7			18,667			110.5
	Provision for doubtful accounts		(1,579	)		(8.7	)		(1,777	)		(10.5	)
	Revenues	$	18,062			100	%	$	16,890			100	%
	The increase in Medicaid revenues for the quarter and the six months ended June 30, 2014 compared to the quarter and six months ended June 30, 2013 was primarily due to our recording of $142 million, or $0.20 per diluted share, of Medicaid revenues related to the receipt of reimbursements in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013.
	Certain prior year amounts have been reclassified to conform to the current year presentation.
Recent Pronouncements	'
	Recent Pronouncements
	In May 2014, the Financial Accounting Standards Board and the International Accounting Standards Board issued a final, converged, principles-based standard on revenue recognition. Companies across all industries will use a new five-step model to recognize revenue from customer contracts. The new standard, which replaces nearly all existing United States Generally Accepted Accounting Principles (“US GAAP”) and International Financial Reporting Standards revenue recognition guidance, will require significant management judgment in addition to changing the way many companies recognize revenue in their financial statements. The standard is effective for public entities for annual and interim periods beginning after December 15, 2016. Early adoption is not permitted under US GAAP. We are evaluating the effects the adoption of this standard will have on our financial statements and financial disclosures.
Earning Per Share	'
	We compute basic earnings per share using the weighted average number of common shares outstanding. We compute diluted earnings per share using the weighted average number of common shares outstanding, plus the dilutive effect of outstanding stock options, stock appreciation rights and restricted share units, computed using the treasury stock method.
Interest Rate Swap Agreements	'
	Interest Rate Swap Agreements
	We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. These swap agreements involve the exchange of fixed and variable rate interest payments between two parties based on common notional principal amounts and maturity dates. Pay-fixed interest rate swaps effectively convert LIBOR indexed variable rate obligations to fixed interest rate obligations. The interest payments under these agreements are settled on a net basis. The net interest payments, based on the notional amounts in these agreements, generally match the timing of the related liabilities for the interest rate swap agreements which have been designated as cash flow hedges. The notional amounts of the swap agreements represent amounts used to calculate the exchange of cash flows and are not our assets or liabilities. Our credit risk related to these agreements is considered low because the swap agreements are with creditworthy financial institutions.
Fair Value Measurements and Disclosures	'
	Accounting Standards Codification 820, Fair Value Measurements and Disclosures (“ASC 820”) emphasizes fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions market participants would use in pricing the asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy).
	Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates, and yield curves observable at commonly quoted intervals. Level 3 inputs are unobservable inputs for the asset or liability, which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input significant to the fair value measurement in its entirety. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.
Cash Traded Investments	'
	Cash Traded Investments
	Our cash traded investments are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. Certain types of cash traded instruments are classified within Level 3 of the fair value hierarchy because they trade infrequently and therefore have little or no price transparency. The valuation of these securities involves management’s judgment, after consideration of market factors and the absence of market transparency, market liquidity and observable inputs. Our valuation models derived fair market values compared to tax-equivalent yields of other securities of similar credit worthiness and similar effective maturities.
Derivative Financial Instruments	'
	Derivative Financial Instruments
	We have entered into interest rate swap agreements to manage our exposure to fluctuations in interest rates. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. We incorporate credit valuation adjustments to reflect both our own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.
	Although we determined the majority of the inputs used to value our derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with our derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by us and our counterparties. We assessed the significance of the impact of the credit valuation adjustments on the overall valuation of our derivative positions, and at March 31, 2014 and December 31, 2013, we determined the credit valuation adjustments were not significant to the overall valuation of our derivatives.

BASIS_OF_PRESENTATION_AND_SIGN2

BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Schedule of Revenues from Third Party Payers and Uninsured	'
	Our revenues from third-party payers and the uninsured for the quarters and six months ended June 30, 2014 and 2013 are summarized in the following table (dollars in millions):
		Quarter
		2014			Ratio			2013			Ratio
	Medicare	$	2,040			22.1	%	$	1,976			23.4	%
	Managed Medicare		906			9.8			804			9.5
	Medicaid		588			6.4			365			4.3
	Managed Medicaid		452			4.9			378			4.5
	Managed care and other insurers		4,959			53.8			4,655			55.1
	International (managed care and other insurers)		334			3.6			291			3.4
			9,279			100.6			8,469			100.2
	Uninsured		318			3.4			693			8.2
	Other		361			3.9			311			3.7
	Revenues before provision for doubtful accounts		9,958			107.9			9,473			112.1
	Provision for doubtful accounts		(728	)		(7.9	)		(1,023	)		(12.1	)
	Revenues	$	9,230			100	%	$	8,450			100	%
		Six Months
		2014			Ratio			2013			Ratio
	Medicare	$	4,165			23.1	%	$	4,114			24.4	%
	Managed Medicare		1,805			10			1,647			9.8
	Medicaid		1,032			5.7			697			4.1
	Managed Medicaid		873			4.8			779			4.6
	Managed care and other insurers		9,669			53.5			9,141			54.1
	International (managed care and other insurers)		660			3.7			581			3.4
			18,204			100.8			16,959			100.4
	Uninsured		706			3.9			1,092			6.5
	Other		731			4			616			3.6
	Revenues before provision for doubtful accounts		19,641			108.7			18,667			110.5
	Provision for doubtful accounts		(1,579	)		(8.7	)		(1,777	)		(10.5	)
	Revenues	$	18,062			100	%	$	16,890			100	%

EARNINGS_PER_SHARE_Tables

EARNINGS PER SHARE (Tables)	6 Months Ended
	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Computations of Basic and Diluted Earnings Per Share	'
	The following table sets forth the computation of basic and diluted earnings per share for the quarters and six months ended June 30, 2014 and 2013 (dollars in millions, except per share amounts, and shares in thousands):
		Quarter				Six Months
		2014		2013		2014		2013
	Net income attributable to HCA Holdings, Inc.	$	483	$	423	$	830	$	767
	Weighted average common shares outstanding		438,833		446,612		440,482		445,513
	Effect of dilutive incremental shares		14,176		16,572		14,738		17,269
	Shares used for diluted earnings per share		453,009		463,184		455,220		462,782
	Earnings per share:
	Basic earnings per share	$	1.1	$	0.95	$	1.88	$	1.72
	Diluted earnings per share	$	1.07	$	0.91	$	1.82	$	1.66

INVESTMENTS_OF_INSURANCE_SUBSI1

INVESTMENTS OF INSURANCE SUBSIDIARIES (Tables)	6 Months Ended
	Jun. 30, 2014
Investments Debt And Equity Securities [Abstract]	'
Schedule of Investments	'
	A summary of our insurance subsidiaries’ investments at June 30, 2014 and December 31, 2013 follows (dollars in millions):
		June 30, 2014
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	447	$	17	$	(1	)	$	463
	Money market funds		29		—		—			29
			476		17		(1	)		492
	Equity securities		1		2		—			3
		$	477	$	19	$	(1	)		495
	Amounts classified as current assets									(69	)
	Investment carrying value								$	426
		December 31, 2013
		Amortized		Unrealized					Fair
		Cost		Amounts					Value
				Gains		Losses
	Debt securities:
	States and municipalities	$	404	$	11	$	(3	)	$	412
	Money market funds		94		—		—			94
			498		11		(3	)		506
	Equity securities		2		2		—			4
		$	500	$	13	$	(3	)		510
	Amounts classified as current assets									(62	)
	Investment carrying value								$	448
Schedule of Maturities of Investments	'
	Scheduled maturities of investments in debt securities at June 30, 2014 were as follows (dollars in millions):
		Amortized		Fair
		Cost		Value
	Due in one year or less	$	41	$	41
	Due after one year through five years		232		238
	Due after five years through ten years		90		96
	Due after ten years		113		117
		$	476	$	492

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	6 Months Ended
	Jun. 30, 2014
Derivative Instruments And Hedging Activities Disclosure [Abstract]	'
Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges	'
	The following table sets forth our interest rate swap agreements, which have been designated as cash flow hedges, at June 30, 2014 (dollars in millions):
		Notional		Maturity Date		Fair
		Amount				Value
	Pay-fixed interest rate swaps	$	500		December 2014	$	(3	)
	Pay-fixed interest rate swaps		3,000		December 2016		(214	)
	Pay-fixed interest rate swaps		1,000		December 2017		(42	)
Effect of Interest Rate on Results of Operations	'
	The following table presents the effect of our interest rate swaps on our results of operations for the six months ended June 30, 2014 (dollars in millions):
	Derivatives in Cash Flow Hedging Relationships	Amount of Loss		Location of Loss		Amount of Loss
		Recognized in OCI on		Reclassified from		Reclassified from
		Derivatives, Net of  Tax		Accumulated OCI		Accumulated OCI
				into Operations		into Operations
	Interest rate swaps	$	19		Interest expense	$	65

ASSETS_AND_LIABILITIES_MEASURE1

ASSETS AND LIABILITIES MEASURED AT FAIR VALUE (Tables)	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	The following tables summarize our assets and liabilities measured at fair value on a recurring basis as of June 30, 2014 and December 31, 2013, aggregated by the level in the fair value hierarchy within which those measurements fall (dollars in millions):
		June 30, 2014
		Fair Value			Fair Value Measurements Using
					Quoted Prices in			Significant Other			Significant
					Active Markets for			Observable Inputs			Unobservable Inputs
					Identical Assets			(Level 2)			(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	463		$	—		$	456		$	7
	Money market funds		29			29			—			—
			492			29			456			7
	Equity securities		3			2			—			1
	Investments of insurance subsidiaries		495			31			456			8
	Less amounts classified as current assets		(69	)		(29	)		(40	)		—
		$	426		$	2		$	416		$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	259		$	—		$	259		$	—
		December 31, 2013
					Fair Value Measurements Using
		Fair Value			Quoted Prices in			Significant Other			Significant
					Active Markets for			Observable Inputs			Unobservable Inputs
					Identical Assets			(Level 2)			(Level 3)
					and Liabilities
					(Level 1)
	Assets:
	Investments of insurance subsidiaries:
	Debt securities:
	States and municipalities	$	412		$	—		$	405		$	7
	Money market funds		94			94			—			—
			506			94			405			7
	Equity securities		4			3			—			1
	Investments of insurance subsidiaries		510			97			405			8
	Less amounts classified as current assets		(62	)		(62	)		—			—
		$	448		$	35		$	405		$	8
	Liabilities:
	Interest rate swaps (Income taxes and other liabilities)	$	295		$	—		$	295		$	—

LONGTERM_DEBT_Tables

LONG-TERM DEBT (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-Term Debt	'
	A summary of long-term debt at June 30, 2014 and December 31, 2013, including related interest rates at June 30, 2014, follows (dollars in millions):
		June 30,		December 31,
		2014		2013
	Senior secured asset-based revolving credit facility (effective interest rate of 1.7%)	$	2,500	$	2,440
	Senior secured revolving credit facility (effective interest rate of 1.7%)		280		—
	Senior secured term loan facilities (effective interest rate of 5.3%)		5,558		5,598
	Senior secured first lien notes (effective interest rate of 5.8%)		10,491		9,695
	Other senior secured debt (effective interest rate of 6.7%)		464		448
	First lien debt		19,293		18,181
	Senior unsecured notes (effective interest rate of 7.2%)		9,695		10,195
	Total debt (average life of 6.4 years, rates averaging 5.8%)		28,988		28,376
	Less amounts due within one year		1,046		786
		$	27,942	$	27,590

CAPITAL_STRUCTURE_Tables

CAPITAL STRUCTURE (Tables)	6 Months Ended
	Jun. 30, 2014
Text Block [Abstract]	'
Schedule of Changes in Stockholders' Deficit and Equity	'
	The changes in stockholders’ deficit, including changes in stockholders’ deficit attributable to HCA Holdings, Inc. and changes in equity attributable to noncontrolling interests, are as follows (dollars in millions):
		Equity (Deficit) Attributable to HCA Holdings, Inc.														Equity			Total
																Attributable to
		Common Stock					Capital in			Accumulated			Retained			Noncontrolling
							Excess of			Other			Deficit			Interests
							Par			Comprehensive
		Shares			Par Value		Value			Loss
		0
	Balances at December 31, 2013		439,604		$	4	$	1,386		$	(257	)	$	(9,403	)	$	1,342		$	(6,928	)
	Net income		—			—		—			—			830			256			1,086
	Repurchase of common stock		(14,555	)		—		(750	)		—			—			—			(750	)
	Other comprehensive income		—			—		—			58			—			—			58
	Distributions		—			—		—			—			—			(197	)		(197	)
	Share-based benefit plans		6,324			—		146			—			—			—			146
	Other		—			—		(5	)		—			1			1			(3	)
	Balances at June 30, 2014		431,373		$	4	$	777		$	(199	)	$	(8,572	)	$	1,402		$	(6,588	)
Components of Accumulated Other Comprehensive Loss	'
	The components of accumulated other comprehensive loss are as follows (dollars in millions):
		Unrealized			Foreign		Defined			Change			Total
		Gains on			Currency		Benefit			in Fair
		Available-			Translation		Plans			Value of
		for-Sale			Adjustments					Derivative
		Securities								Instruments
	Balances at December 31, 2013	$	7		$	11	$	(88	)	$	(187	)	$	(257	)
	Unrealized gains on available-for-sale securities, net of $3 of income taxes		5			—		—			—			5
	Foreign currency translation adjustments, net of $14 of income taxes		—			26		—			—			26
	Change in fair value of derivative instruments, net of $10 income tax benefit		—			—		—			(19	)		(19	)
	Expense reclassified into operations from other comprehensive income, net of $3 and $24, respectively, income tax benefits		—			—		5			41			46
	Balances at June 30, 2014	$	12		$	37	$	(83	)	$	(165	)	$	(199	)

SEGMENT_AND_GEOGRAPHIC_INFORMA1

SEGMENT AND GEOGRAPHIC INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA and Depreciation and Amortization	'
	The geographic distributions of our revenues, equity in earnings of affiliates, adjusted segment EBITDA and depreciation and amortization for the quarters and six months ended June 30, 2014 and 2013 are summarized in the following table (dollars in millions):
		Quarter						Six Months
		2014			2013			2014			2013
	Revenues:
	National Group	$	4,267		$	3,964		$	8,427		$	7,945
	American Group		4,447			4,065			8,599			8,099
	Corporate and other		516			421			1,036			846
		$	9,230		$	8,450		$	18,062		$	16,890
	Equity in earnings of affiliates:
	National Group	$	(3	)	$	(3	)	$	(6	)	$	(5	)
	American Group		(8	)		(7	)		(15	)		(13	)
	Corporate and other		2			(2	)		3			(2	)
		$	(9	)	$	(12	)	$	(18	)	$	(20	)
	Adjusted segment EBITDA:
	National Group	$	946		$	831		$	1,802		$	1,635
	American Group		1,134			916			1,984			1,744
	Corporate and other		(80	)		(58	)		(142	)		(122	)
		$	2,000		$	1,689		$	3,644		$	3,257
	Depreciation and amortization:
	National Group	$	190		$	177		$	377		$	351
	American Group		211			202			416			404
	Corporate and other		53			46			108			94
		$	454		$	425		$	901		$	849
	Adjusted segment EBITDA	$	2,000		$	1,689		$	3,644		$	3,257
	Depreciation and amortization		454			425			901			849
	Interest expense		427			462			887			934
	Losses (gains) on sales of facilities		(11	)		(4	)		(32	)		12
	Losses on retirement of debt		226			—			226			17
	Legal claim costs		—			—			78			—
	Income before income taxes	$	904		$	806		$	1,584		$	1,445

SUPPLEMENTAL_CONDENSED_CONSOLI1

SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION (Tables)	6 Months Ended
	Jun. 30, 2014
Text Block [Abstract]	'
Schedule of Condensed Consolidating Comprehensive Income Statement	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE QUARTER ENDED JUNE 30, 2014
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Revenues before provision for doubtful accounts	$	—		$	—		$	5,079		$	4,879		$	—		$	9,958
	Provision for doubtful accounts		—			—			394			334			—			728
	Revenues		—			—			4,685			4,545			—			9,230
	Salaries and benefits		—			—			2,118			1,980			—			4,098
	Supplies		—			—			805			727			—			1,532
	Other operating expenses		5			—			789			850			—			1,644
	Electronic health record incentive income		—			—			(24	)		(11	)		—			(35	)
	Equity in earnings of affiliates		(549	)		—			(1	)		(8	)		549			(9	)
	Depreciation and amortization		—			—			224			230			—			454
	Interest expense		46			536			(112	)		(43	)		—			427
	Gains on sales of facilities		—			—			(11	)		—			—			(11	)
	Losses on retirement of debt		—			226			—			—			—			226
	Management fees		—			—			(176	)		176			—			—
			(498	)		762			3,612			3,901			549			8,326
	Income (loss) before income taxes		498			(762	)		1,073			644			(549	)		904
	Provision (benefit) for income taxes		(18	)		(277	)		381			186			—			272
	Net income (loss)		516			(485	)		692			458			(549	)		632
	Net income attributable to noncontrolling interests		—			—			18			131			—			149
	Net income (loss) attributable to HCA Holdings, Inc.	$	516		$	(485	)	$	674		$	327		$	(549	)	$	483
	Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	516		$	(477	)	$	677		$	349		$	(549	)	$	516
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE QUARTER ENDED JUNE 30, 2013
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Revenues before provision for doubtful accounts	$	—		$	—		$	5,012		$	4,461		$	—		$	9,473
	Provision for doubtful accounts		—			—			608			415			—			1,023
	Revenues		—			—			4,404			4,046			—			8,450
	Salaries and benefits		—			—			2,058			1,790			—			3,848
	Supplies		—			—			776			694			—			1,470
	Other operating expenses		1			—			757			749			—			1,507
	Electronic health record incentive income		—			—			(33	)		(19	)		—			(52	)
	Equity in earnings of affiliates		(504	)		—			(1	)		(11	)		504			(12	)
	Depreciation and amortization		—			—			211			214			—			425
	Interest expense		51			544			(109	)		(24	)		—			462
	Losses (gains) on sales of facilities		—			—			3			(7	)		—			(4	)
	Management fees		—			—			(181	)		181			—			—
			(452	)		544			3,481			3,567			504			7,644
	Income (loss) before income taxes		452			(544	)		923			479			(504	)		806
	Provision (benefit) for income taxes		(20	)		(213	)		354			148			—			269
	Net income (loss)		472			(331	)		569			331			(504	)		537
	Net income attributable to noncontrolling interests		—			—			16			98			—			114
	Net income (loss) attributable to HCA Holdings, Inc.	$	472		$	(331	)	$	553		$	233		$	(504	)	$	423
	Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	472		$	(283	)	$	558		$	229		$	(504	)	$	472
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
	FOR THE SIX MONTHS ENDED JUNE 30, 2014
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Revenues before provision for doubtful accounts	$	—		$	—		$	10,109		$	9,532		$	—		$	19,641
	Provision for doubtful accounts		—			—			931			648			—			1,579
	Revenues		—			—			9,178			8,884			—			18,062
Salaries and benefits		—			—			4,217			3,931			—			8,148
Supplies		—			—			1,619			1,445			—			3,064
Other operating expenses		10			—			1,562			1,717			—			3,289
Electronic health record incentive income		—			—			(46	)		(19	)		—			(65	)
Equity in earnings of affiliates		(952	)		—			(2	)		(16	)		952			(18	)
Depreciation and amortization		—			—			442			459			—			901
Interest expense		92			1,093			(234	)		(64	)		—			887
Gains on sales of facilities		—			—			(32	)		—			—			(32	)
Losses on retirement of debt		—			226			—			—			—			226
Legal claim costs		—			78			—			—			—			78
Management fees		—			—			(350	)		350			—			—
		(850	)		1,397			7,176			7,803			952			16,478
Income (loss) before income taxes		850			(1,397	)		2,002			1,081			(952	)		1,584
Provision (benefit) for income taxes		(38	)		(524	)		733			327			—			498
Net income (loss)		888			(873	)		1,269			754			(952	)		1,086
Net income attributable to noncontrolling interests		—			—			47			209			—			256
Net income (loss) attributable to HCA Holdings, Inc.	$	888		$	(873	)	$	1,222		$	545		$	(952	)	$	830
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	888		$	(851	)	$	1,227		$	576		$	(952	)	$	888
HCA HOLDINGS, INC.
CONDENSED CONSOLIDATING COMPREHENSIVE INCOME STATEMENT
FOR THE SIX MONTHS ENDED JUNE 30, 2013
(Dollars in millions)
	HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
	Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
	Issuer									Guarantors
Revenues before provision for doubtful accounts	$	—		$	—		$	9,884		$	8,783		$	—		$	18,667
Provision for doubtful accounts		—			—			1,051			726			—			1,777
Revenues		—			—			8,833			8,057			—			16,890
Salaries and benefits		—			—			4,185			3,580			—			7,765
Supplies		—			—			1,567			1,382			—			2,949
Other operating expenses		2			—			1,489			1,539			—			3,030
Electronic health record incentive income		—			—			(62	)		(29	)		—			(91	)
Equity in earnings of affiliates		(860	)		—			(2	)		(18	)		860			(20	)
Depreciation and amortization		—			—			420			429			—			849
Interest expense		97			1,102			(215	)		(50	)		—			934
Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
Loss on retirement of debt		—			17			—			—			—			17
Management fees		—			—			(364	)		364			—			—
		(761	)		1,119			7,037			7,190			860			15,445
Income (loss) before income taxes		761			(1,119	)		1,796			867			(860	)		1,445
Provision (benefit) for income taxes		(37	)		(425	)		671			261			—			470
Net income (loss)		798			(694	)		1,125			606			(860	)		975
Net income attributable to noncontrolling interests		—			—			29			179			—			208
Net income (loss) attributable to HCA Holdings, Inc.	$	798		$	(694	)	$	1,096		$	427		$	(860	)	$	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	$	798		$	(630	)	$	1,105		$	385		$	(860	)	$	798
Schedule of Condensed Consolidating Balance Sheet	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING BALANCE SHEET
	30-Jun-14
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	ASSETS
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	215		$	443		$	—		$	658
	Accounts receivable, net		—			—			2,709			2,763			—			5,472
	Inventories		—			—			707			504			—			1,211
	Deferred income taxes		500			—			—			—			—			500
	Other		—			—			344			587			—			931
			500			—			3,975			4,297			—			8,772
	Property and equipment, net		—			—			7,676			6,045			—			13,721
	Investments of insurance subsidiaries		—			—			—			426			—			426
	Investments in and advances to affiliates		21,308			—			15			135			(21,308	)		150
	Goodwill and other intangible assets		—			—			1,694			4,215			—			5,909
	Deferred loan costs		27			203			—			—			—			230
	Other		406			—			19			189			—			614
		$	22,241		$	203		$	13,379		$	15,307		$	(21,308	)	$	29,822
	LIABILITIES AND
	STOCKHOLDERS’ (DEFICIT)
	EQUITY
	Current liabilities:
	Accounts payable	$	4		$	—		$	1,081		$	632		$	—		$	1,717
	Accrued salaries		—			—			656			484			—			1,140
	Other accrued expenses		407			330			433			822			—			1,992
	Long-term debt due within one year		—			952			50			44			—			1,046
			411			1,282			2,220			1,982			—			5,895
	Long-term debt		2,525			25,047			183			187			—			27,942
	Intercompany balances		26,762			(10,203	)		(20,098	)		3,539			—			—
	Professional liability risks		—			—			—			1,019			—			1,019
	Income taxes and other liabilities		533			260			543			218			—			1,554
			30,231			16,386			(17,152	)		6,945			—			36,410
	Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(7,990	)		(16,183	)		30,412			7,079			(21,308	)		(7,990	)
	Noncontrolling interests		—			—			119			1,283			—			1,402
			(7,990	)		(16,183	)		30,531			8,362			(21,308	)		(6,588	)
		$	22,241		$	203		$	13,379		$	15,307		$	(21,308	)	$	29,822
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING BALANCE SHEET
	31-Dec-13
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	ASSETS
	Current assets:
	Cash and cash equivalents	$	—		$	—		$	112		$	302		$	—		$	414
	Accounts receivable, net		—			—			2,565			2,643			—			5,208
	Inventories		—			—			692			487			—			1,179
	Deferred income taxes		489			—			—			—			—			489
	Other		—			—			301			446			—			747
			489			—			3,670			3,878			—			8,037
	Property and equipment, net		—			—			7,504			6,115			—			13,619
	Investments of insurance subsidiaries		—			—			—			448			—			448
	Investments in and advances to affiliates		20,356			—			13			108			(20,356	)		121
	Goodwill and other intangible assets		—			—			1,695			4,208			—			5,903
	Deferred loan costs		30			207			—			—			—			237
	Other		250			—			48			168			—			466
		$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
	LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY
Current liabilities:
Accounts payable	$	1		$	—		$	1,169		$	633		$	—		$	1,803
Accrued salaries		—			—			694			499			—			1,193
Other accrued expenses		272			353			464			824			—			1,913
Long-term debt due within one year		—			702			45			39			—			786
		273			1,055			2,372			1,995			—			5,695
Long-term debt		2,525			24,701			181			183			—			27,590
Intercompany balances		26,107			(10,513	)		(19,428	)		3,834			—			—
Professional liability risks		—			—			—			949			—			949
Income taxes and other liabilities		490			296			521			218			—			1,525
		29,395			15,539			(16,354	)		7,179			—			35,759
Stockholders’ (deficit) equity attributable to HCA Holdings, Inc.		(8,270	)		(15,332	)		29,185			6,503			(20,356	)		(8,270	)
Noncontrolling interests		—			—			99			1,243			—			1,342
		(8,270	)		(15,332	)		29,284			7,746			(20,356	)		(6,928	)
	$	21,125		$	207		$	12,930		$	14,925		$	(20,356	)	$	28,831
Schedule of Condensed Consolidating Statement of Cash Flows	'
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	FOR THE SIX MONTHS ENDED JUNE 30, 2014
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Cash flows from operating activities:
	Net income (loss)	$	888		$	(873	)	$	1,269		$	754		$	(952	)	$	1,086
	Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
	Changes in operating assets and liabilities		13			(32	)		(1,258	)		(874	)		—			(2,151	)
	Provision for doubtful accounts		—			—			931			648			—			1,579
	Depreciation and amortization		—			—			442			459			—			901
	Income taxes		(94	)		—			—			—			—			(94	)
	Gains on sales of facilities		—			—			(32	)		—			—			(32	)
	Losses on retirement of debt		—			226			—			—			—			226
	Legal claim costs		—			78			—			—			—			78
	Amortization of deferred loan costs		2			21			—			—			—			23
	Share-based compensation		77			—			—			—			—			77
	Equity in earnings of affiliates		(952	)		—			—			—			952			—
	Other		—			1			—			(1	)		—			—
	Net cash (used in) provided by operating activities		(66	)		(579	)		1,352			986			—			1,693
	Cash flows from investing activities:
	Purchase of property and equipment		—			—			(583	)		(330	)		—			(913	)
	Acquisition of hospitals and health care entities		—			—			(2	)		(25	)		—			(27	)
	Disposition of hospitals and health care entities		—			—			25			7			—			32
	Change in investments		—			—			26			17			—			43
	Other		—			—			—			1			—			1
	Net cash used in investing activities		—			—			(534	)		(330	)		—			(864	)
	Cash flows from financing activities:
	Issuance of long-term debt		—			3,502			—			—			—			3,502
	Net change in revolving credit facilities		—			340			—			—			—			340
	Repayment of long-term debt		—			(3,441	)		(25	)		(16	)		—			(3,482	)
	Distributions to noncontrolling interests		—			—			(27	)		(170	)		—			(197	)
	Payment of debt issuance costs		—			(49	)		—			—			—			(49	)
	Repurchase of common stock		(750	)		—			—			—			—			(750	)
	Distributions to stockholders		(7	)		—			—			—			—			(7	)
	Changes in intercompany balances with affiliates, net		756			227			(663	)		(320	)		—			—
	Income tax benefits		75			—			—			—			—			75
	Other		(8	)		—			—			(9	)		—			(17	)
	Net cash provided by (used in) financing activities		66			579			(715	)		(515	)		—			(585	)
	Change in cash and cash equivalents		—			—			103			141			—			244
	Cash and cash equivalents at beginning of period		—			—			112			302			—			414
	Cash and cash equivalents at end of period	$	—		$	—		$	215		$	443		$	—		$	658
	HCA HOLDINGS, INC.
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	FOR THE SIX MONTHS ENDED JUNE 30, 2013
	(Dollars in millions)
		HCA			HCA Inc.			Subsidiary			Subsidiary			Eliminations			Condensed
		Holdings, Inc.			Issuer			Guarantors			Non-						Consolidated
		Issuer									Guarantors
	Cash flows from operating activities:
	Net income (loss)	$	798		$	(694	)	$	1,125		$	606		$	(860	)	$	975
	Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
	Changes in operating assets and liabilities		41			(18	)		(1,217	)		(1,141	)		—			(2,335	)
	Provision for doubtful accounts		—			—			1,051			726			—			1,777
	Depreciation and amortization		—			—			420			429			—			849
	Income taxes		183			—			—			—			—			183
	Losses (gains) on sales of facilities		—			—			19			(7	)		—			12
	Loss on retirement of debt		—			17			—			—			—			17
	Amortization of deferred loan costs		2			26			—			—			—			28
	Share-based compensation		51			—			—			—			—			51
	Equity in earnings of affiliates		(860	)		—			—			—			860			—
Other		—			4			—			(7	)		—			(3	)
Net cash provided by (used in) operating activities		215			(665	)		1,398			606			—			1,554
Cash flows from investing activities:
Purchase of property and equipment		—			—			(434	)		(462	)		—			(896	)
Acquisition of hospitals and health care entities		—			—			—			(23	)		—			(23	)
Disposition of hospitals and health care entities		—			—			17			14			—			31
Change in investments		—			—			5			97			—			102
Other		—			—			(1	)		(3	)		—			(4	)
Net cash used in investing activities		—			—			(413	)		(377	)		—			(790	)
Cash flows from financing activities:
Net change in revolving credit facilities		—			(20	)		—			—			—			(20	)
Repayment of long-term debt		—			(726	)		(22	)		(20	)		—			(768	)
Distributions to noncontrolling interests		—			—			(29	)		(167	)		—			(196	)
Payment of debt issuance costs		—			(5	)		—			—			—			(5	)
Distributions to stockholders		(10	)		—			—			—			—			(10	)
Changes in intercompany balances with affiliates, net		(216	)		1,416			(1,165	)		(35	)		—			—
Income tax benefits		61			—			—			—			—			61
Other		(72	)		—			—			3			—			(69	)
Net cash (used in) provided by financing activities		(237	)		665			(1,216	)		(219	)		—			(1,007	)
Change in cash and cash equivalents		(22	)		—			(231	)		10			—			(243	)
Cash and cash equivalents at beginning of period		22			—			383			300			—			705
Cash and cash equivalents at end of period	$	—		$	—		$	152		$	310		$	—		$	462

Recovered_Sheet1

Basis of Presentation and Significant Accounting Policies - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
	Hospital		Hospital
	State		State
	Surgery_Center		Surgery_Center
Accounting Policies [Abstract]	'	'	'	'
Number of owned and operated hospitals	165	'	165	'
Number of freestanding surgery centers	115	'	115	'
Number of facilities locations	20	'	20	'
General and administrative expense	$67	$65	$135	$131
Adjustments to Medicare revenues	$142	'	$142	'
Adjustment to increase Medicaid revenues in diluted per share	$0.20	'	$0.20	'

Recovered_Sheet2

Basis of Presentation and Significant Accounting Policies - Schedule of Revenues from Third Party Payers and Uninsured (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	$9,279	$8,469	$18,204	$16,959
Uninsured	318	693	706	1,092
Other	361	311	731	616
Revenues before provision for doubtful accounts	9,958	9,473	19,641	18,667
Provision for doubtful accounts	-728	-1,023	-1,579	-1,777
Revenues	9,230	8,450	18,062	16,890
Revenues from third party payers, Ratio	100.60%	100.20%	100.80%	100.40%
Uninsured, Ratio	3.40%	8.20%	3.90%	6.50%
Other, Ratio	3.90%	3.70%	4.00%	3.60%
Revenues before provision for doubtful accounts, Ratio	107.90%	112.10%	108.70%	110.50%
Revenues before provision for doubtful accounts, Ratio	107.90%	112.10%	108.70%	110.50%
Provision for doubtful accounts, Ratio	-7.90%	-12.10%	-8.70%	-10.50%
Revenues ratio from third party payers	100.00%	100.00%	100.00%	100.00%
Medicare [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	2,040	1,976	4,165	4,114
Revenues from third party payers, Ratio	22.10%	23.40%	23.10%	24.40%
Managed Medicare [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	906	804	1,805	1,647
Revenues from third party payers, Ratio	9.80%	9.50%	10.00%	9.80%
Medicaid [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	588	365	1,032	697
Revenues from third party payers, Ratio	6.40%	4.30%	5.70%	4.10%
Managed Medicaid [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	452	378	873	779
Revenues from third party payers, Ratio	4.90%	4.50%	4.80%	4.60%
Managed Care and Other Insurers [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	4,959	4,655	9,669	9,141
Revenues from third party payers, Ratio	53.80%	55.10%	53.50%	54.10%
International (Managed Care and Other Insurers) [Member]	'	'	'	'
Revenues From Third Party Payers [Line Items]	'	'	'	'
Revenues from third party payers	$334	$291	$660	$581
Revenues from third party payers, Ratio	3.60%	3.40%	3.70%	3.40%

Acquisitions_and_Dispositions_

Acquisitions and Dispositions - Additional Information (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Business Acquisition [Line Items]	'	'
Proceeds from sale of business	$32	$31
Real Estate and Other Investments [Member]	'	'
Business Acquisition [Line Items]	'	'
Pretax gain (loss) on sales of business	32	'
Proceeds from sale of business	32	'
Hospitals [Member]	'	'
Business Acquisition [Line Items]	'	'
Cash paid for acquisition	14	'
Hospitals [Member] | Real Estate and Other Investments [Member]	'	'
Business Acquisition [Line Items]	'	'
Pretax gain (loss) on sales of business	'	-12
Proceeds from sale of business	'	31
Other Nonhospital Health Care [Member]	'	'
Business Acquisition [Line Items]	'	'
Cash paid for acquisition	$13	$23

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'	'	'	'	'
Liability for unrecognized tax benefits	$507	'	$507	'	$462
Unrecognized tax benefits, accrued interest	40	'	40	'	30
Unrecognized tax benefits that would impact effective tax rate	176	'	176	'	160
Interest expense related to taxing authority examinations	4	3	'	'	'
Reductions in interest expense related to taxing authority examinations	'	'	8	15	'
Interest expense related to taxing authority examinations, net of tax	2	2	'	'	'
Reductions in interest expense related to taxing authority examinations, net of tax	'	'	5	9	'
Provision for income taxes, reduction related primarily to resolutions for prior year examinations	$22	'	$22	'	'

Earnings_Per_Share_Schedule_of

Earnings Per Share - Schedule of Computations of Basic and Diluted Earnings Per Share (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Share data in Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income attributable to HCA Holdings, Inc.	$483	$423	$830	$767
Weighted average common shares outstanding	438,833	446,612	440,482	445,513
Effect of dilutive incremental shares	14,176	16,572	14,738	17,269
Shares used for diluted earnings per share	453,009	463,184	455,220	462,782
Basic earnings per share	$1.10	$0.95	$1.88	$1.72
Diluted earnings per share	$1.07	$0.91	$1.82	$1.66

Recovered_Sheet3

Investments of Insurance Subsidiaries - Schedule of Investments (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	$477	$500
Unrealized Amounts, Gains	19	13
Unrealized Amounts, Losses	-1	-3
Fair Value	495	510
Amounts classified as current assets	-69	-62
Investment carrying value	426	448
Debt Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	476	498
Unrealized Amounts, Gains	17	11
Unrealized Amounts, Losses	-1	-3
Fair Value	492	506
Debt Securities [Member] | States and Municipalities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	447	404
Unrealized Amounts, Gains	17	11
Unrealized Amounts, Losses	-1	-3
Fair Value	463	412
Debt Securities [Member] | Money Market Funds [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	29	94
Unrealized Amounts, Gains	'	'
Unrealized Amounts, Losses	'	'
Fair Value	29	94
Equity Securities [Member]	'	'
Schedule of Trading Securities and Other Trading Assets [Line Items]	'	'
Amortized Cost	1	2
Unrealized Amounts, Gains	2	2
Unrealized Amounts, Losses	'	'
Fair Value	$3	$4

Recovered_Sheet4

Investments of Insurance Subsidiaries - Schedule of Maturities of Investments (Detail) (USD $)	Jun. 30, 2014
In Millions, unless otherwise specified
Amortized Cost And Fair Value Debt Securities [Abstract]	'
Due in one year or less, Amortized Cost	$41
Due after one year through five years, Amortized Cost	232
Due after five years through ten years, Amortized Cost	90
Due after ten years, Amortized Cost	113
Amortized Cost, Total	476
Due in one year or less, Fair Value	41
Due after one year through five years, Fair Value	238
Due after five years through ten years, Fair Value	96
Due after ten years, Fair Value	117
Fair Value, Total	$492

Investments_of_Insurance_Subsi2

Investments of Insurance Subsidiaries - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2014
Amortized Cost And Fair Value Debt Securities [Abstract]	'
Available for sale securities expected maturity of debt securities	'4 years 1 month 6 days
Available for sale securities average scheduled maturity	'5 years 8 months 12 days

Financial_Instruments_Schedule

Financial Instruments - Schedule of Interest Rate Swap Agreements Designated as Cash Flow Hedges (Detail) (Pay-Fixed Interest Rate Swaps [Member], USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Maturity Date, 2014 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	$500
Fair Value	-3
Maturity Date	31-Dec-14
Maturity Date, 2016 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	3,000
Fair Value	-214
Maturity Date	31-Dec-16
Maturity Date, 2017 [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Notional Amount	1,000
Fair Value	($42)
Maturity Date	31-Dec-17

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Offsetting [Abstract]	'
Estimated amount reclassified from other comprehensive income to interest expense	$126
Estimated termination value if there is breach of provision related to derivative agreement	$269

Financial_Instruments_Effect_o

Financial Instruments - Effect of Interest Rate Swaps on Results of Operations (Detail) (Interest Rate Swaps [Member], USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Derivative Instruments, Gain (Loss) [Line Items]	'
Amount of Loss Recognized in OCI on Derivatives, Net of Tax	$19
Interest Expense [Member]	'
Derivative Instruments, Gain (Loss) [Line Items]	'
Amount of Loss Reclassified from Accumulated OCI into Operations	$65

Recovered_Sheet5

Assets and Liabilities Measured at Fair Value - Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	$495	$510
Less amounts classified as current assets	-69	-62
Investments of insurance subsidiaries, noncurrent	426	448
Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	259	295
Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	492	506
Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	463	412
Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	29	94
Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	3	4
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	31	97
Less amounts classified as current assets	-29	-62
Investments of insurance subsidiaries, noncurrent	2	35
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	29	94
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	29	94
Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	2	3
Significant Other Observable Inputs (Level 2) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	456	405
Less amounts classified as current assets	-40	'
Investments of insurance subsidiaries, noncurrent	416	405
Significant Other Observable Inputs (Level 2) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	259	295
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	456	405
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	456	405
Significant Other Observable Inputs (Level 2) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Other Observable Inputs (Level 2) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	8	8
Less amounts classified as current assets	'	'
Investments of insurance subsidiaries, noncurrent	8	8
Significant Unobservable Inputs (Level 3) [Member] | Interest Rate Swaps [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Liabilities, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	7	7
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | States and Municipalities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	7	7
Significant Unobservable Inputs (Level 3) [Member] | Debt Securities [Member] | Money Market Funds [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	'	'
Significant Unobservable Inputs (Level 3) [Member] | Equity Securities [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Assets, Fair Value	$1	$1

Recovered_Sheet6

Assets and Liabilities Measured at Fair Value - Additional Information (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Fair Value Disclosures [Abstract]	'	'
Estimated fair value of long-term debt	$30,449	$29,603
Carrying amounts of long-term debt	$28,988	$28,376

LongTerm_Debt_Schedule_of_Long

Long-Term Debt - Schedule of Long-Term Debt (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'	'
First lien debt	$19,293	$18,181
Total debt (average life of 6.4 years, rates averaging 5.8%)	28,988	28,376
Less amounts due within one year	1,046	786
Long-term debt	27,942	27,590
Senior Secured Asset-Based Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term line of credit	2,500	2,440
Senior Secured Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Long-term line of credit	280	'
Senior Secured Term Loan Facilities [Member]	'	'
Debt Instrument [Line Items]	'	'
Term loans	5,558	5,598
Senior Secured First Lien Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Senior secured first lien notes	10,491	9,695
Other Senior Secured Debt [Member]	'	'
Debt Instrument [Line Items]	'	'
Other senior secured debt (effective interest rate of 6.5%)	464	448
Senior Unsecured Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Senior unsecured notes	$9,695	$10,195

LongTerm_Debt_Schedule_of_Long1

Long-Term Debt - Schedule of Long-Term Debt (Parenthetical) (Detail)	6 Months Ended
	Jun. 30, 2014
Debt Instrument [Line Items]	'
Total debt average term	'6 years 4 months 24 days
Total debt average rate	5.80%
Senior Secured Asset-Based Revolving Credit Facility [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	1.70%
Senior Secured Revolving Credit Facility [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	1.70%
Senior Secured Term Loan Facilities [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	5.30%
Senior Secured First Lien Notes [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	5.80%
Other Senior Secured Debt [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	6.70%
Senior Unsecured Notes [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	7.20%

LongTerm_Debt_Additional_Infor

Long-Term Debt - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Mar. 31, 2013	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2014	Mar. 31, 2013	Apr. 30, 2014	Mar. 31, 2014	Mar. 31, 2014	Apr. 30, 2014	Apr. 30, 2014
						Senior Secured Second Lien Notes Due 2017 [Member]	Senior Secured Notes Due 2019 [Member]	Senior Secured Notes Due 2019 [Member]	Senior Secured Notes Due 2024 [Member]	Senior Secured Notes Due 2020 [Member]	Senior Unsecured Notes Due 2014 [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Debt instrument, principal amount	'	'	'	'	$3,500	'	'	$1,500	$2,000	'	'
Debt instrument, stated interest	'	'	'	'	'	9.88%	8.50%	3.75%	5.00%	7.88%	5.75%
Redemption of aggregate principal amount	'	'	'	'	'	'	1,500	'	'	1,250	500
Pretax loss on retirement of debt	226	17	226	17	'	'	'	'	'	'	'
Redemption of aggregate principal amount	'	'	'	'	'	$201	'	'	'	'	'

Recovered_Sheet7

Contingencies and Legal Claim Costs - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended	6 Months Ended		0 Months Ended	3 Months Ended	6 Months Ended
In Millions, unless otherwise specified	Oct. 28, 2011	Dec. 31, 2012	Jun. 30, 2014	Dec. 31, 2003	Jan. 24, 2013	Dec. 31, 2012	Jun. 30, 2014	Jul. 31, 2012
	Cases		Hospital		Pending Litigation [Member]	Pending Litigation [Member]	Pending Litigation [Member]	Florida [Member]
					Health Care Foundation of Greater Kansas City [Member]	Health Care Foundation of Greater Kansas City [Member]	Health Care Foundation of Greater Kansas City [Member]	Hospital
Schedule Of Activities Related To Claims Filed [Line Items]	'	'	'	'	'	'	'	'
Number of owned and operated hospitals reviewed	'	'	95	'	'	'	'	8
Number of claims filed	3	'	'	'	'	'	'	'
Capital commitments in connection with purchase of hospitals	'	'	'	$450	'	'	'	'
Legal claim costs	'	175	78	'	'	'	'	'
Judgment award by the court	'	'	'	'	162	'	'	'
Period of agreed capital commitments	'	'	'5 years	'	'	'	'	'
Number of year under court-supervisor accounting for expenditures following the purchase	'	'	'10 years	'	'	'	'	'
Plaintiff attorneys fees award	'	'	'	'	'	'	$12	'
Percentage of legal claim costs	'	'	'	'	'	9.00%	'	'

Capital_Structure_Schedule_of_

Capital Structure - Schedule of Changes in Stockholders' Deficit and Equity (Detail) (USD $)	3 Months Ended		6 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	($6,928)	'
Net income	632	537	1,086	975
Repurchase of common stock	'	'	-750	'
Other comprehensive income	33	49	58	31
Distributions	'	'	-197	'
Share-based benefit plans	'	'	146	'
Other	'	'	-3	'
Ending Balances	-6,588	'	-6,588	'
Repurchase of common stock, Shares	'	'	14,554,628	'
Common Stock [Member]	'	'	'	'
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	4	'
Net income	'	'	0	'
Repurchase of common stock	'	'	0	'
Other comprehensive income	'	'	0	'
Distributions	'	'	0	'
Share-based benefit plans	'	'	0	'
Other	'	'	0	'
Ending Balances	4	'	4	'
Beginning Balances, Shares	'	'	439,604	'
Repurchase of common stock, Shares	'	'	-14,555	'
Share-based benefit plans, Shares	'	'	6,324	'
Ending Balances, Shares	431,373	'	431,373	'
Capital in Excess of Par Value [Member]	'	'	'	'
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	1,386	'
Net income	'	'	0	'
Repurchase of common stock	'	'	-750	'
Other comprehensive income	'	'	0	'
Distributions	'	'	0	'
Share-based benefit plans	'	'	146	'
Other	'	'	-5	'
Ending Balances	777	'	777	'
Accumulated Other Comprehensive Loss [Member]	'	'	'	'
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	-257	'
Net income	'	'	0	'
Repurchase of common stock	'	'	0	'
Other comprehensive income	'	'	58	'
Distributions	'	'	0	'
Share-based benefit plans	'	'	0	'
Other	'	'	0	'
Ending Balances	-199	'	-199	'
Retained Deficit [Member]	'	'	'	'
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	-9,403	'
Net income	'	'	830	'
Repurchase of common stock	'	'	0	'
Other comprehensive income	'	'	0	'
Distributions	'	'	0	'
Share-based benefit plans	'	'	0	'
Other	'	'	1	'
Ending Balances	-8,572	'	-8,572	'
Equity Attributable to Noncontrolling Interests [Member]	'	'	'	'
Capital Structure [Line Items]	'	'	'	'
Beginning Balances	'	'	1,342	'
Net income	'	'	256	'
Repurchase of common stock	'	'	0	'
Other comprehensive income	'	'	0	'
Distributions	'	'	-197	'
Share-based benefit plans	'	'	0	'
Other	'	'	1	'
Ending Balances	$1,402	'	$1,402	'

Capital_Structure_Additional_I

Capital Structure - Additional Information (Detail) (USD $)	6 Months Ended
	Jun. 30, 2014
Equity [Abstract]	'
Repurchase of common stock	14,554,628
Repurchase of common stock, per share	$51.53

Capital_Structure_Components_o

Capital Structure - Components of Accumulated Other Comprehensive Loss (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Equity [Abstract]	'
Unrealized gains on available-for-sale securities, beginning balances	$7
Unrealized gains on available-for-sale securities, net of income taxes	5
Unrealized gains on available-for-sale securities, ending balances	12
Foreign currency translation adjustments, beginning balances	11
Foreign currency translation adjustments	26
Foreign currency translation adjustments, ending balances	37
Defined benefit plans, beginning balances	-88
Defined benefit plans, (income) expense reclassified into operations from other comprehensive income	5
Defined benefit plans, ending balances	-83
Change in fair value of derivative instruments, beginning balances	-187
Change in fair value of derivative instruments	-19
Change in fair value of derivatives instruments, (income) expense reclassified into operations from other comprehensive income	41
Change in fair value of derivative instruments, ending balances	-165
Accumulated other comprehensive income, net of tax, beginning balances	-257
Unrealized gains on available-for-sale securities, net of income taxes	5
Foreign currency translation adjustments	26
Change in fair value of derivative instruments	-19
Expense reclassified into operations from other comprehensive income, Total	46
Accumulated other comprehensive income (loss), net of tax, ending balances	($199)

Capital_Structure_Components_o1

Capital Structure - Components of Accumulated Other Comprehensive Loss (Parenthetical) (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014
Equity [Abstract]	'
Foreign currency translation adjustments, income taxes	$14
Defined benefit plans, income tax benefits	3
Change in fair value of derivative instruments, Expense reclassified into operations from other comprehensive income, income tax benefits	24
Unrealized gains on available-for-sale securities, income taxes	3
Change in fair value of derivative instruments, income tax benefit	$10

Recovered_Sheet8

Segment and Geographic Information - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2014
	Hospital
Segment Reporting Information [Line Items]	'
Number of geographically organized groups	2
Number of owned and operated hospitals	165
National Group [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	82
American Group [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	77
Corporate and Other [Member]	'
Segment Reporting Information [Line Items]	'
Number of owned and operated hospitals	6

Recovered_Sheet9

Segment and Geographic Information - Schedule of Geographic Distributions of Revenues, Equity in Earnings of Affiliates, Adjusted Segment EBITDA and Depreciation and Amortization (Detail) (USD $)	3 Months Ended				6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2014	Jun. 30, 2013
Segment Reporting Information [Line Items]	'	'	'	'	'	'
Revenues	$9,230	$8,450	'	'	$18,062	$16,890
Equity in earnings of affiliates	-9	-12	'	'	-18	-20
Adjusted segment EBITDA	2,000	1,689	'	'	3,644	3,257
Depreciation and amortization	454	425	'	'	901	849
Interest expense	427	462	'	'	887	934
Losses (gains) on sales of facilities	-11	-4	'	'	-32	12
Losses on retirement of debt	226	'	17	'	226	17
Legal claim costs	'	'	'	175	78	'
Income before income taxes	904	806	'	'	1,584	1,445
National Group [Member]	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'
Revenues	4,267	3,964	'	'	8,427	7,945
Equity in earnings of affiliates	-3	-3	'	'	-6	-5
Adjusted segment EBITDA	946	831	'	'	1,802	1,635
Depreciation and amortization	190	177	'	'	377	351
American Group [Member]	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'
Revenues	4,447	4,065	'	'	8,599	8,099
Equity in earnings of affiliates	-8	-7	'	'	-15	-13
Adjusted segment EBITDA	1,134	916	'	'	1,984	1,744
Depreciation and amortization	211	202	'	'	416	404
Corporate and Other [Member]	'	'	'	'	'	'
Segment Reporting Information [Line Items]	'	'	'	'	'	'
Revenues	516	421	'	'	1,036	846
Equity in earnings of affiliates	2	-2	'	'	3	-2
Adjusted segment EBITDA	-80	-58	'	'	-142	-122
Depreciation and amortization	$53	$46	'	'	$108	$94

Recovered_Sheet10

Supplemental Condensed Consolidating Financial Information - Additional Information (Detail) (USD $)	Jun. 30, 2014	Mar. 31, 2014	Dec. 06, 2012	Nov. 23, 2010
In Millions, unless otherwise specified			Senior Unsecured Notes Due 2021 [Member]	Senior Unsecured Notes Due 2021 [Member]
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'
Debt instrument, principal amount	'	$3,500	$1,000	$1,525
Debt instrument, stated interest	'	'	6.25%	7.75%
Ownership percentage held by parent	100.00%	'	'	'

Recovered_Sheet11

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Comprehensive Income Statement (Detail) (USD $)	3 Months Ended				6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Jun. 30, 2014	Jun. 30, 2013
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	$9,958	$9,473	'	'	$19,641	$18,667
Provision for doubtful accounts	728	1,023	'	'	1,579	1,777
Revenues	9,230	8,450	'	'	18,062	16,890
Salaries and benefits	4,098	3,848	'	'	8,148	7,765
Supplies	1,532	1,470	'	'	3,064	2,949
Other operating expenses	1,644	1,507	'	'	3,289	3,030
Electronic health record incentive income	-35	-52	'	'	-65	-91
Equity in earnings of affiliates	-9	-12	'	'	-18	-20
Depreciation and amortization	454	425	'	'	901	849
Interest expense	427	462	'	'	887	934
Gains on sales of facilities	-11	-4	'	'	-32	12
Losses on retirement of debt	226	'	17	'	226	17
Legal claim costs	'	'	'	175	78	'
Management fees	'	'	'	'	'	'
Total expenses including equity in earnings of affiliates	8,326	7,644	'	'	16,478	15,445
Income (loss) before income taxes	904	806	'	'	1,584	1,445
Provision (benefit) for income taxes	272	269	'	'	498	470
Net income (loss)	632	537	'	'	1,086	975
Net income attributable to noncontrolling interests	149	114	'	'	256	208
Net income (loss) attributable to HCA Holdings, Inc.	483	423	'	'	830	767
Comprehensive income (loss) attributable to HCA Holdings, Inc.	516	472	'	'	888	798
HCA Holdings, Inc. Issuer [Member]	'	'	'	'	'	'
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	'	'	'	'	'	'
Provision for doubtful accounts	'	'	'	'	'	'
Revenues	'	'	'	'	'	'
Salaries and benefits	'	'	'	'	'	'
Supplies	'	'	'	'	'	'
Other operating expenses	5	1	'	'	10	2
Electronic health record incentive income	'	'	'	'	'	'
Equity in earnings of affiliates	-549	-504	'	'	-952	-860
Depreciation and amortization	'	'	'	'	'	'
Interest expense	46	51	'	'	92	97
Gains on sales of facilities	'	'	'	'	'	'
Losses on retirement of debt	'	'	'	'	'	'
Legal claim costs	'	'	'	'	'	'
Management fees	'	'	'	'	'	'
Total expenses including equity in earnings of affiliates	-498	-452	'	'	-850	-761
Income (loss) before income taxes	498	452	'	'	850	761
Provision (benefit) for income taxes	-18	-20	'	'	-38	-37
Net income (loss)	516	472	'	'	888	798
Net income attributable to noncontrolling interests	'	'	'	'	'	'
Net income (loss) attributable to HCA Holdings, Inc.	516	472	'	'	888	798
Comprehensive income (loss) attributable to HCA Holdings, Inc.	516	472	'	'	888	798
HCA Inc. Issuer [Member]	'	'	'	'	'	'
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	'	'	'	'	'	'
Provision for doubtful accounts	'	'	'	'	'	'
Revenues	'	'	'	'	'	'
Salaries and benefits	'	'	'	'	'	'
Supplies	'	'	'	'	'	'
Other operating expenses	'	'	'	'	'	'
Electronic health record incentive income	'	'	'	'	'	'
Equity in earnings of affiliates	'	'	'	'	'	'
Depreciation and amortization	'	'	'	'	'	'
Interest expense	536	544	'	'	1,093	1,102
Gains on sales of facilities	'	'	'	'	'	'
Losses on retirement of debt	226	'	'	'	226	17
Legal claim costs	'	'	'	'	78	'
Management fees	'	'	'	'	'	'
Total expenses including equity in earnings of affiliates	762	544	'	'	1,397	1,119
Income (loss) before income taxes	-762	-544	'	'	-1,397	-1,119
Provision (benefit) for income taxes	-277	-213	'	'	-524	-425
Net income (loss)	-485	-331	'	'	-873	-694
Net income attributable to noncontrolling interests	'	'	'	'	'	'
Net income (loss) attributable to HCA Holdings, Inc.	-485	-331	'	'	-873	-694
Comprehensive income (loss) attributable to HCA Holdings, Inc.	-477	-283	'	'	-851	-630
Subsidiary Guarantors [Member]	'	'	'	'	'	'
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	5,079	5,012	'	'	10,109	9,884
Provision for doubtful accounts	394	608	'	'	931	1,051
Revenues	4,685	4,404	'	'	9,178	8,833
Salaries and benefits	2,118	2,058	'	'	4,217	4,185
Supplies	805	776	'	'	1,619	1,567
Other operating expenses	789	757	'	'	1,562	1,489
Electronic health record incentive income	-24	-33	'	'	-46	-62
Equity in earnings of affiliates	-1	-1	'	'	-2	-2
Depreciation and amortization	224	211	'	'	442	420
Interest expense	-112	-109	'	'	-234	-215
Gains on sales of facilities	-11	3	'	'	-32	19
Losses on retirement of debt	'	'	'	'	'	'
Legal claim costs	'	'	'	'	'	'
Management fees	-176	-181	'	'	-350	-364
Total expenses including equity in earnings of affiliates	3,612	3,481	'	'	7,176	7,037
Income (loss) before income taxes	1,073	923	'	'	2,002	1,796
Provision (benefit) for income taxes	381	354	'	'	733	671
Net income (loss)	692	569	'	'	1,269	1,125
Net income attributable to noncontrolling interests	18	16	'	'	47	29
Net income (loss) attributable to HCA Holdings, Inc.	674	553	'	'	1,222	1,096
Comprehensive income (loss) attributable to HCA Holdings, Inc.	677	558	'	'	1,227	1,105
Subsidiary Non-Guarantors [Member]	'	'	'	'	'	'
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	4,879	4,461	'	'	9,532	8,783
Provision for doubtful accounts	334	415	'	'	648	726
Revenues	4,545	4,046	'	'	8,884	8,057
Salaries and benefits	1,980	1,790	'	'	3,931	3,580
Supplies	727	694	'	'	1,445	1,382
Other operating expenses	850	749	'	'	1,717	1,539
Electronic health record incentive income	-11	-19	'	'	-19	-29
Equity in earnings of affiliates	-8	-11	'	'	-16	-18
Depreciation and amortization	230	214	'	'	459	429
Interest expense	-43	-24	'	'	-64	-50
Gains on sales of facilities	'	-7	'	'	'	-7
Losses on retirement of debt	'	'	'	'	'	'
Legal claim costs	'	'	'	'	'	'
Management fees	176	181	'	'	350	364
Total expenses including equity in earnings of affiliates	3,901	3,567	'	'	7,803	7,190
Income (loss) before income taxes	644	479	'	'	1,081	867
Provision (benefit) for income taxes	186	148	'	'	327	261
Net income (loss)	458	331	'	'	754	606
Net income attributable to noncontrolling interests	131	98	'	'	209	179
Net income (loss) attributable to HCA Holdings, Inc.	327	233	'	'	545	427
Comprehensive income (loss) attributable to HCA Holdings, Inc.	349	229	'	'	576	385
Eliminations [Member]	'	'	'	'	'	'
Supplemental Condensed Consolidating Financial Information [Line Items]	'	'	'	'	'	'
Revenues before provision for doubtful accounts	'	'	'	'	'	'
Provision for doubtful accounts	'	'	'	'	'	'
Revenues	'	'	'	'	'	'
Salaries and benefits	'	'	'	'	'	'
Supplies	'	'	'	'	'	'
Other operating expenses	'	'	'	'	'	'
Electronic health record incentive income	'	'	'	'	'	'
Equity in earnings of affiliates	549	504	'	'	952	860
Depreciation and amortization	'	'	'	'	'	'
Interest expense	'	'	'	'	'	'
Gains on sales of facilities	'	'	'	'	'	'
Losses on retirement of debt	'	'	'	'	'	'
Legal claim costs	'	'	'	'	'	'
Management fees	'	'	'	'	'	'
Total expenses including equity in earnings of affiliates	549	504	'	'	952	860
Income (loss) before income taxes	-549	-504	'	'	-952	-860
Provision (benefit) for income taxes	'	'	'	'	'	'
Net income (loss)	-549	-504	'	'	-952	-860
Net income attributable to noncontrolling interests	'	'	'	'	'	'
Net income (loss) attributable to HCA Holdings, Inc.	-549	-504	'	'	-952	-860
Comprehensive income (loss) attributable to HCA Holdings, Inc.	($549)	($504)	'	'	($952)	($860)

Supplemental_Condensed_Consoli2

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Balance Sheet (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
In Millions, unless otherwise specified
Current assets:	'	'	'	'
Cash and cash equivalents	$658	$414	$462	$705
Accounts receivable, net	5,472	5,208	'	'
Inventories	1,211	1,179	'	'
Deferred income taxes	500	489	'	'
Other	931	747	'	'
Total current assets	8,772	8,037	'	'
Property and equipment, net	13,721	13,619	'	'
Investments of insurance subsidiaries	426	448	'	'
Investments in and advances to affiliates	150	121	'	'
Goodwill and other intangible assets	5,909	5,903	'	'
Deferred loan costs	230	237	'	'
Other	614	466	'	'
Total assets	29,822	28,831	'	'
Current liabilities:	'	'	'	'
Accounts payable	1,717	1,803	'	'
Accrued salaries	1,140	1,193	'	'
Other accrued expenses	1,992	1,913	'	'
Long-term debt due within one year	1,046	786	'	'
Total current liabilities	5,895	5,695	'	'
Long-term debt	27,942	27,590	'	'
Intercompany balances	'	'	'	'
Professional liability risks	1,019	949	'	'
Income taxes and other liabilities	1,554	1,525	'	'
Total liabilities	36,410	35,759	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-7,990	-8,270	'	'
Noncontrolling interests	1,402	1,342	'	'
Total stockholders' deficit	-6,588	-6,928	'	'
Total liabilities and stockholders' deficit	29,822	28,831	'	'
HCA Holdings, Inc. Issuer [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	22
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	500	489	'	'
Other	'	'	'	'
Total current assets	500	489	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	21,308	20,356	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	27	30	'	'
Other	406	250	'	'
Total assets	22,241	21,125	'	'
Current liabilities:	'	'	'	'
Accounts payable	4	1	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	407	272	'	'
Long-term debt due within one year	'	'	'	'
Total current liabilities	411	273	'	'
Long-term debt	2,525	2,525	'	'
Intercompany balances	26,762	26,107	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	533	490	'	'
Total liabilities	30,231	29,395	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-7,990	-8,270	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-7,990	-8,270	'	'
Total liabilities and stockholders' deficit	22,241	21,125	'	'
HCA Inc. Issuer [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	'
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	'	'	'	'
Other	'	'	'	'
Total current assets	'	'	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	'	'	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	203	207	'	'
Other	'	'	'	'
Total assets	203	207	'	'
Current liabilities:	'	'	'	'
Accounts payable	'	'	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	330	353	'	'
Long-term debt due within one year	952	702	'	'
Total current liabilities	1,282	1,055	'	'
Long-term debt	25,047	24,701	'	'
Intercompany balances	-10,203	-10,513	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	260	296	'	'
Total liabilities	16,386	15,539	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-16,183	-15,332	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-16,183	-15,332	'	'
Total liabilities and stockholders' deficit	203	207	'	'
Subsidiary Guarantors [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	215	112	152	383
Accounts receivable, net	2,709	2,565	'	'
Inventories	707	692	'	'
Deferred income taxes	'	'	'	'
Other	344	301	'	'
Total current assets	3,975	3,670	'	'
Property and equipment, net	7,676	7,504	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	15	13	'	'
Goodwill and other intangible assets	1,694	1,695	'	'
Deferred loan costs	'	'	'	'
Other	19	48	'	'
Total assets	13,379	12,930	'	'
Current liabilities:	'	'	'	'
Accounts payable	1,081	1,169	'	'
Accrued salaries	656	694	'	'
Other accrued expenses	433	464	'	'
Long-term debt due within one year	50	45	'	'
Total current liabilities	2,220	2,372	'	'
Long-term debt	183	181	'	'
Intercompany balances	-20,098	-19,428	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	543	521	'	'
Total liabilities	-17,152	-16,354	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	30,412	29,185	'	'
Noncontrolling interests	119	99	'	'
Total stockholders' deficit	30,531	29,284	'	'
Total liabilities and stockholders' deficit	13,379	12,930	'	'
Subsidiary Non-Guarantors [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	443	302	310	300
Accounts receivable, net	2,763	2,643	'	'
Inventories	504	487	'	'
Deferred income taxes	'	'	'	'
Other	587	446	'	'
Total current assets	4,297	3,878	'	'
Property and equipment, net	6,045	6,115	'	'
Investments of insurance subsidiaries	426	448	'	'
Investments in and advances to affiliates	135	108	'	'
Goodwill and other intangible assets	4,215	4,208	'	'
Deferred loan costs	'	'	'	'
Other	189	168	'	'
Total assets	15,307	14,925	'	'
Current liabilities:	'	'	'	'
Accounts payable	632	633	'	'
Accrued salaries	484	499	'	'
Other accrued expenses	822	824	'	'
Long-term debt due within one year	44	39	'	'
Total current liabilities	1,982	1,995	'	'
Long-term debt	187	183	'	'
Intercompany balances	3,539	3,834	'	'
Professional liability risks	1,019	949	'	'
Income taxes and other liabilities	218	218	'	'
Total liabilities	6,945	7,179	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	7,079	6,503	'	'
Noncontrolling interests	1,283	1,243	'	'
Total stockholders' deficit	8,362	7,746	'	'
Total liabilities and stockholders' deficit	15,307	14,925	'	'
Eliminations [Member]	'	'	'	'
Current assets:	'	'	'	'
Cash and cash equivalents	'	'	'	'
Accounts receivable, net	'	'	'	'
Inventories	'	'	'	'
Deferred income taxes	'	'	'	'
Other	'	'	'	'
Total current assets	'	'	'	'
Property and equipment, net	'	'	'	'
Investments of insurance subsidiaries	'	'	'	'
Investments in and advances to affiliates	-21,308	-20,356	'	'
Goodwill and other intangible assets	'	'	'	'
Deferred loan costs	'	'	'	'
Other	'	'	'	'
Total assets	-21,308	-20,356	'	'
Current liabilities:	'	'	'	'
Accounts payable	'	'	'	'
Accrued salaries	'	'	'	'
Other accrued expenses	'	'	'	'
Long-term debt due within one year	'	'	'	'
Total current liabilities	'	'	'	'
Long-term debt	'	'	'	'
Intercompany balances	'	'	'	'
Professional liability risks	'	'	'	'
Income taxes and other liabilities	'	'	'	'
Total liabilities	'	'	'	'
Stockholders' (deficit) equity attributable to HCA Holdings, Inc.	-21,308	-20,356	'	'
Noncontrolling interests	'	'	'	'
Total stockholders' deficit	-21,308	-20,356	'	'
Total liabilities and stockholders' deficit	($21,308)	($20,356)	'	'

Supplemental_Condensed_Consoli3

Supplemental Condensed Consolidating Financial Information - Schedule of Condensed Consolidating Statement of Cash Flows (Detail) (USD $)	6 Months Ended
In Millions, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:	'	'
Net income (loss)	$1,086	$975
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	-2,151	-2,335
Provision for doubtful accounts	1,579	1,777
Depreciation and amortization	901	849
Income taxes	-94	183
Gains on sales of facilities	-32	12
Losses on retirement of debt	226	17
Legal claim costs	78	'
Amortization of deferred loan costs	23	28
Share-based compensation	77	51
Equity in earnings of affiliates	'	'
Other	'	-3
Net cash provided by operating activities	1,693	1,554
Cash flows from investing activities:	'	'
Purchase of property and equipment	-913	-896
Acquisition of hospitals and health care entities	-27	-23
Disposition of hospitals and health care entities	32	31
Change in investments	43	102
Other	1	-4
Net cash used in investing activities	-864	-790
Cash flows from financing activities:	'	'
Issuance of long-term debt	3,502	'
Net change in revolving credit facilities	340	-20
Repayment of long-term debt	-3,482	-768
Distributions to noncontrolling interests	-197	-196
Payment of debt issuance costs	-49	-5
Repurchase of common stock	-750	'
Distributions to stockholders	-7	-10
Changes in intercompany balances with affiliates, net	'	'
Income tax benefits	75	61
Other	-17	-69
Net cash used in financing activities	-585	-1,007
Change in cash and cash equivalents	244	-243
Cash and cash equivalents at beginning of period	414	705
Cash and cash equivalents at end of period	658	462
HCA Holdings, Inc. Issuer [Member]	'	'
Cash flows from operating activities:	'	'
Net income (loss)	888	798
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	13	41
Provision for doubtful accounts	'	'
Depreciation and amortization	'	'
Income taxes	-94	183
Gains on sales of facilities	'	'
Losses on retirement of debt	'	'
Legal claim costs	'	'
Amortization of deferred loan costs	2	2
Share-based compensation	77	51
Equity in earnings of affiliates	-952	-860
Other	'	'
Net cash provided by operating activities	-66	215
Cash flows from investing activities:	'	'
Purchase of property and equipment	'	'
Acquisition of hospitals and health care entities	'	'
Disposition of hospitals and health care entities	'	'
Change in investments	'	'
Other	'	'
Net cash used in investing activities	'	'
Cash flows from financing activities:	'	'
Issuance of long-term debt	'	'
Net change in revolving credit facilities	'	'
Repayment of long-term debt	'	'
Distributions to noncontrolling interests	'	'
Payment of debt issuance costs	'	'
Repurchase of common stock	-750	'
Distributions to stockholders	-7	-10
Changes in intercompany balances with affiliates, net	756	-216
Income tax benefits	75	61
Other	-8	-72
Net cash used in financing activities	66	-237
Change in cash and cash equivalents	'	-22
Cash and cash equivalents at beginning of period	'	22
Cash and cash equivalents at end of period	'	'
HCA Inc. Issuer [Member]	'	'
Cash flows from operating activities:	'	'
Net income (loss)	-873	-694
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	-32	-18
Provision for doubtful accounts	'	'
Depreciation and amortization	'	'
Income taxes	'	'
Gains on sales of facilities	'	'
Losses on retirement of debt	226	17
Legal claim costs	78	'
Amortization of deferred loan costs	21	26
Share-based compensation	'	'
Equity in earnings of affiliates	'	'
Other	1	4
Net cash provided by operating activities	-579	-665
Cash flows from investing activities:	'	'
Purchase of property and equipment	'	'
Acquisition of hospitals and health care entities	'	'
Disposition of hospitals and health care entities	'	'
Change in investments	'	'
Other	'	'
Net cash used in investing activities	'	'
Cash flows from financing activities:	'	'
Issuance of long-term debt	3,502	'
Net change in revolving credit facilities	340	-20
Repayment of long-term debt	-3,441	-726
Distributions to noncontrolling interests	'	'
Payment of debt issuance costs	-49	-5
Repurchase of common stock	'	'
Distributions to stockholders	'	'
Changes in intercompany balances with affiliates, net	227	1,416
Income tax benefits	0	'
Other	'	'
Net cash used in financing activities	579	665
Change in cash and cash equivalents	'	'
Cash and cash equivalents at beginning of period	'	'
Cash and cash equivalents at end of period	'	'
Subsidiary Guarantors [Member]	'	'
Cash flows from operating activities:	'	'
Net income (loss)	1,269	1,125
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	-1,258	-1,217
Provision for doubtful accounts	931	1,051
Depreciation and amortization	442	420
Income taxes	'	'
Gains on sales of facilities	-32	19
Losses on retirement of debt	'	'
Legal claim costs	'	'
Amortization of deferred loan costs	'	'
Share-based compensation	'	'
Equity in earnings of affiliates	'	'
Other	'	'
Net cash provided by operating activities	1,352	1,398
Cash flows from investing activities:	'	'
Purchase of property and equipment	-583	-434
Acquisition of hospitals and health care entities	-2	'
Disposition of hospitals and health care entities	25	17
Change in investments	26	5
Other	'	-1
Net cash used in investing activities	-534	-413
Cash flows from financing activities:	'	'
Issuance of long-term debt	'	'
Net change in revolving credit facilities	'	'
Repayment of long-term debt	-25	-22
Distributions to noncontrolling interests	-27	-29
Payment of debt issuance costs	'	'
Repurchase of common stock	'	'
Distributions to stockholders	'	'
Changes in intercompany balances with affiliates, net	-663	-1,165
Income tax benefits	'	'
Other	'	'
Net cash used in financing activities	-715	-1,216
Change in cash and cash equivalents	103	-231
Cash and cash equivalents at beginning of period	112	383
Cash and cash equivalents at end of period	215	152
Subsidiary Non-Guarantors [Member]	'	'
Cash flows from operating activities:	'	'
Net income (loss)	754	606
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	-874	-1,141
Provision for doubtful accounts	648	726
Depreciation and amortization	459	429
Income taxes	'	'
Gains on sales of facilities	'	-7
Losses on retirement of debt	'	'
Legal claim costs	'	'
Amortization of deferred loan costs	'	'
Share-based compensation	'	'
Equity in earnings of affiliates	'	'
Other	-1	-7
Net cash provided by operating activities	986	606
Cash flows from investing activities:	'	'
Purchase of property and equipment	-330	-462
Acquisition of hospitals and health care entities	-25	-23
Disposition of hospitals and health care entities	7	14
Change in investments	17	97
Other	1	-3
Net cash used in investing activities	-330	-377
Cash flows from financing activities:	'	'
Issuance of long-term debt	'	'
Net change in revolving credit facilities	'	'
Repayment of long-term debt	-16	-20
Distributions to noncontrolling interests	-170	-167
Payment of debt issuance costs	'	'
Repurchase of common stock	'	'
Distributions to stockholders	'	'
Changes in intercompany balances with affiliates, net	-320	-35
Income tax benefits	'	'
Other	-9	3
Net cash used in financing activities	-515	-219
Change in cash and cash equivalents	141	10
Cash and cash equivalents at beginning of period	302	300
Cash and cash equivalents at end of period	443	310
Eliminations [Member]	'	'
Cash flows from operating activities:	'	'
Net income (loss)	-952	-860
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:	'	'
Changes in operating assets and liabilities	'	'
Provision for doubtful accounts	'	'
Depreciation and amortization	'	'
Income taxes	'	'
Gains on sales of facilities	'	'
Losses on retirement of debt	'	'
Legal claim costs	'	'
Amortization of deferred loan costs	'	'
Share-based compensation	'	'
Equity in earnings of affiliates	952	860
Other	'	'
Net cash provided by operating activities	'	'
Cash flows from investing activities:	'	'
Purchase of property and equipment	'	'
Acquisition of hospitals and health care entities	'	'
Disposition of hospitals and health care entities	'	'
Change in investments	'	'
Other	'	'
Net cash used in investing activities	'	'
Cash flows from financing activities:	'	'
Issuance of long-term debt	'	'
Net change in revolving credit facilities	'	'
Repayment of long-term debt	'	'
Distributions to noncontrolling interests	'	'
Payment of debt issuance costs	'	'
Repurchase of common stock	'	'
Distributions to stockholders	'	'
Changes in intercompany balances with affiliates, net	'	'
Income tax benefits	'	'
Other	'	'
Net cash used in financing activities	'	'
Change in cash and cash equivalents	'	'
Cash and cash equivalents at beginning of period	'	'
Cash and cash equivalents at end of period	'	'